{"gene":"CCR2","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1994,"finding":"CCR2 was molecularly cloned as the MCP-1 (CCL2) receptor; expression in Xenopus oocytes demonstrated that CCR2 confers robust intracellular calcium mobilization in response to nanomolar MCP-1 but not related chemokines, establishing it as a G protein-coupled, seven-transmembrane receptor with two isoforms (CCR2A and CCR2B) arising from alternative splicing of the C-terminal tail.","method":"cDNA cloning, heterologous expression in Xenopus oocytes, calcium flux assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — functional reconstitution in heterologous system with rigorous ligand specificity controls; foundational cloning paper","pmids":["8146186"],"is_preprint":false},{"year":1997,"finding":"CCR2 mRNA stability is regulated by LPS through a two-step process: LPS first triggers deadenylation of CCR2 mRNA, followed by degradation of the message body, rapidly reducing steady-state CCR2 mRNA levels in monocytes.","method":"mRNA stability assay (actinomycin D chase), poly(A) tail analysis, Northern blot","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct biochemical dissection of mRNA decay mechanism in primary cells, single lab","pmids":["9365120"],"is_preprint":false},{"year":1999,"finding":"The CCR2-64I polymorphism (Val64Ile in TM1) is efficiently expressed on the cell surface but does not exert dominant-negative activity on CCR5 coreceptor function, and does not alter CCR5 mRNA or surface expression levels in primary CD4+ T cells, indicating its AIDS-delaying effect is not mediated through CCR5 regulation.","method":"Flow cytometry, RT-PCR, HIV-1 coreceptor function assay, transfected cell reporter constructs","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods with primary cells and transfected constructs; single lab study","pmids":["9971830"],"is_preprint":false},{"year":1999,"finding":"Endothelial cells express functional CCR2 (mRNA and surface protein), and MCP-1 stimulation promotes endothelial cell migration in a transwell assay that is blocked by a CCR2 antagonist (9-76 MCP-1) or anti-MCP-1 antibody, implicating CCR2 in endothelial wound repair.","method":"RT-PCR, RNase protection, Western blot, flow cytometry, transwell migration assay with receptor antagonist, immunohistochemistry","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods with functional receptor antagonist validation; single lab","pmids":["10479649"],"is_preprint":false},{"year":2000,"finding":"CCR2 expressed on pleural mesothelial cells mediates MCP-1-dependent haptotactic migration; blocking CCR2 with neutralizing antibodies abolished haptotaxis, and IL-2 upregulated CCR2 expression correlating with enhanced haptotactic capacity, while LPS initially downregulated it.","method":"FACS analysis of CCR2 expression, neutralizing antibody blockade, haptotaxis assay, RT-PCR","journal":"American journal of physiology. Lung cellular and molecular physiology","confidence":"Medium","confidence_rationale":"Tier 2 — receptor blockade with functional readout, multiple methods; single lab","pmids":["10710532"],"is_preprint":false},{"year":2001,"finding":"Eotaxin acts as a natural CCR2 antagonist: it displaces 125I-MCP-1 from monocytes in a concentration-dependent manner and inhibits MCP-1-induced chemotaxis and enzyme release without triggering CCR2 internalization, whereas it functions as a CCR5 agonist (100 nM) and induces CCR5 internalization.","method":"Radioligand binding assay, chemotaxis assay, receptor internalization assay, enzyme release assay using primary human monocytes and CCR2/CCR5-transfected cells","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 — radioligand binding with functional assays in both primary monocytes and reconstituted transfected cells; multiple orthogonal readouts","pmids":["11264152"],"is_preprint":false},{"year":2001,"finding":"CCR2 and CCR5 undergo ligand-induced heterodimerization; MCP-1 and RANTES cooperate synergistically (10–100-fold lower threshold) when both receptors are co-expressed, recruiting both receptor-associated signaling complexes and additionally engaging Gq/11, resulting in pertussis toxin-resistant Ca2+ flux and cell adhesion rather than chemotaxis.","method":"Co-immunoprecipitation, BRET, Ca2+ flux assay, pertussis toxin treatment, chemotaxis assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 — direct protein interaction demonstrated by co-IP plus distinct functional readouts distinguishing homo- vs. heterodimer signaling outcomes","pmids":["11350939"],"is_preprint":false},{"year":2002,"finding":"Matrix metalloproteinase cleavage of MCP-1 (CCL2) between residues 4 and 5 generates N-terminally truncated forms that bind CCR2 but lack chemoattractant activity and instead act as potent CCR2 antagonists, reducing inflammatory edema >66% in vivo.","method":"Recombinant MMP cleavage assays, radioligand competition binding on CCR2-transfected cells, transwell migration assay, carrageenan paw edema model","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic cleavage with defined products, receptor binding, functional antagonism, and in vivo validation","pmids":["12149192"],"is_preprint":false},{"year":2003,"finding":"Site-directed mutagenesis guided by a rhodopsin-homology model of CCR2 identified specific transmembrane residues required for binding of indole-piperidine class antagonists; docking studies and SDM results together defined the orthosteric antagonist binding pocket within the transmembrane bundle.","method":"Homology modeling (bovine rhodopsin template), site-directed mutagenesis, radioligand binding assay","journal":"Journal of medicinal chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — structure-function mutagenesis with functional binding readout; single lab","pmids":["12954060"],"is_preprint":false},{"year":2004,"finding":"MCP-1 signals through an alternative receptor in CCR2-/- arterial smooth muscle cells at physiologic concentrations; this alternative receptor signals via pertussis toxin-sensitive Gαi, mobilizes intracellular Ca2+, activates p42/44 MAPK, and induces tissue-factor activity—a pathway inhibited by PD98059 (MEK inhibitor) but not SB203580 (p38 inhibitor).","method":"CCR2-/- mouse SMC preparation, pertussis toxin treatment, intracellular Ca2+ measurement, phospho-MAPK immunoblot, tissue-factor activity assay, selective kinase inhibitors","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function genetics combined with pharmacological dissection; single lab, multiple readouts","pmids":["15020650"],"is_preprint":false},{"year":2007,"finding":"CCR2 is essential for monocyte mobilization from bone marrow into blood and for subsequent recruitment from blood to inflamed tissue; CCR2-/- mice accumulate monocytes in bone marrow with decreased circulating numbers, and adoptive transfer of CCR2-/- monocytes into wild-type hosts demonstrates a cell-autonomous requirement for CCR2 in efficient tissue recruitment. MCP-3 and MCP-1 are the critical CCR2 agonists maintaining normal blood monocyte counts.","method":"CCR2-/- and MCP knockout mouse analysis, ex vivo labeling and adoptive transfer, flow cytometry, MCP ligand knockout comparison","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function plus adoptive transfer establishes cell-autonomous CCR2 requirement; replicated across multiple knockout lines","pmids":["17364026"],"is_preprint":false},{"year":2008,"finding":"CCR2 undergoes transportin-1 (TRN1)-dependent nuclear translocation after agonist stimulation; TRN1 directly binds CCR2 (interaction increasing over time with agonist treatment) and promotes receptor internalization and nuclear envelope localization.","method":"Modified CCR2 bait construct, co-immunoprecipitation, confocal microscopy, TRN1 knockdown","journal":"Proteomics","confidence":"Medium","confidence_rationale":"Tier 3 — novel subcellular localization finding; single Co-IP plus imaging, single lab","pmids":["18846510"],"is_preprint":false},{"year":2009,"finding":"CCR2, CCR5, and CXCR4 form hetero-oligomeric complexes of at least three receptors; demonstrated by bimolecular luminescence complementation and BRET. Negative binding cooperativity between binding pockets was shown in T cells and monocytes, and selective CCR2/CCR5 antagonist TAK-779 cross-inhibits CXCR4-promoted cell recruitment in vivo via these oligomeric complexes.","method":"Bimolecular luminescence complementation, BRET, radioligand binding cooperativity assay in primary leukocytes, air-pouch model in vivo","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — two orthogonal FRET/complementation methods plus functional validation in primary cells and in vivo; single lab with multiple methods","pmids":["19758998"],"is_preprint":false},{"year":2009,"finding":"FROUNT binds to the C-terminal region of CCR2 and enhances CCR2-mediated directional chemotaxis by amplifying sensing of shallow chemokine gradients, consolidating pseudopodium formation toward the source; FROUNT suppression results in multiple unfocused pseudopodia and impaired directional response.","method":"Co-immunoprecipitation, overexpression/knockdown, live-cell chemotaxis assay with pseudopod quantification","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 3 — co-IP plus functional phenotype; single lab","pmids":["19841162"],"is_preprint":false},{"year":2009,"finding":"After CCL2 binding, CCR2 internalizes via a combination of clathrin-dependent and clathrin-independent pathways, reaching early endosomes and then lysosomes; dynamin inhibition (dynasore) blocks both CCR2 internalization and ERK1/2 activation, linking dynamin-sensitive endocytosis to downstream signaling.","method":"RNAi knockdown of clathrin, dynasore treatment, confocal microscopy, immunoblot (phospho-ERK1/2)","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and pharmacological perturbation with multiple readouts; single lab","pmids":["19643177"],"is_preprint":false},{"year":2010,"finding":"Beta-defensins 2 and 3 (human) and their mouse orthologs (mBD4 and mBD14) bind CCR2-transfected HEK293 cells and induce CCR2-specific chemotaxis of human monocytes and mouse peritoneal exudate cells; this chemotaxis is abolished by pre-incubation with CCL2/MCP-1 and is absent in CCR2-/- cells, establishing these defensins as functional CCR2 ligands.","method":"Flow cytometry binding assay (Fc-fusion proteins on CCR2-transfected HEK293), chemotaxis assay with CCR2-/- cells, competitive inhibition with CCL2","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — direct binding assay plus functional validation with genetic knockout controls; multiple orthogonal approaches","pmids":["20483750"],"is_preprint":false},{"year":2012,"finding":"SphK1 in hepatic stellate cells upregulates CCR2 expression by downregulating miR-19b-3p (which directly targets CCR2 mRNA), while SphK1 in Kupffer cells promotes CCL2 secretion; this SphK1→miR-19b-3p↓→CCR2↑ axis in HSCs drives their activation and migration in liver fibrosis.","method":"SphK1 knockout mice, bone marrow transplantation, miRNA overexpression/inhibition, qRT-PCR, Western blot, in vitro HSC migration assay","journal":"Hepatology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO plus miRNA mechanistic dissection and BMT validation; single lab","pmids":["29572892"],"is_preprint":false},{"year":2014,"finding":"A group of allosteric CCR2 antagonists (CCR2-RA-[R], JNJ-27141491, SD-24) bind an intracellular site distinct from the orthosteric chemokine-binding pocket; mutagenesis identified Y7.53 and F8.50 of the NPxxYx5,6F motif, V6.36, and K8.49 in helix VIII as critical residues, demonstrating for the first time an intracellular allosteric binding site on CCR2.","method":"Chimeric CCR2/CCR5 receptor approach, site-directed mutagenesis, radioligand binding assay, IP1 functional assay","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1–2 — chimeric receptor mapping plus systematic mutagenesis with functional validation; multiple constructs and readouts","pmids":["25024169"],"is_preprint":false},{"year":2014,"finding":"CCL2 in the CCR2/CCR5 signaling context: CCR2-CCR2 homodimerization is required for Ca2+ flux and chemotaxis, and CCR2/CCR5 heterodimerization recruits Gq/11 and additional signaling pathways leading to cell adhesion; the CCL2-CCR2 axis in human mesangial cells signals through CCR2 to upregulate ICAM-1 expression and enhance monocyte adhesion, blocked by the CCR2 antagonist RS102895.","method":"CCR2 blockade with RS102895, immunofluorescence, cytofluorimetry, RT-PCR, immunoblotting, monocyte adhesion assay","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological CCR2 blockade with multiple cellular readouts; single lab","pmids":["16518346"],"is_preprint":false},{"year":2016,"finding":"Filamin A (FLNa) regulates CCR2B endosomal recycling: FLNa knockdown causes activated CCR2B to accumulate in enlarged EEA-1+ endosomes with impaired exit; FLNa and CCR2B co-localize in actin-enriched endosomal microdomains, and CCR2B signaling induces phosphorylation of FLNa at S2152, which sustains receptor recycling back to the plasma membrane.","method":"FLNa siRNA knockdown, super-resolution microscopy, FRAP, EEA-1 co-localization, phospho-FLNa immunoblot, CCR2B trafficking assay","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — super-resolution imaging plus genetic knockdown and phospho-site identification; single lab with multiple methods","pmids":["27909248"],"is_preprint":false},{"year":2016,"finding":"CYTL1 is identified as a functional CCR2B ligand: it induces CCR2B internalization, ERK pathway-dependent chemotaxis of human monocytes, and macrophage chemotaxis from wild-type but not Ccr2-/- mice; chemotactic activity is sensitive to pertussis toxin, indicating Gi-coupled signaling through CCR2B.","method":"Chemotaxis assay, receptor internalization assay, radioligand competitive binding, pertussis toxin treatment, Ccr2-/- macrophage assay, CCR2B-transfected HEK293 cells","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1–2 — binding, internalization, and functional chemotaxis assays in reconstituted cells and primary cells including genetic knockout validation","pmids":["27084102"],"is_preprint":false},{"year":2017,"finding":"PCSK9, secreted from LPS-stimulated vascular smooth muscle cells via a TLR4-SAPK/JNK pathway, reduces LDL-R on monocytes; this LDL-R reduction limits LDL-C-dependent upregulation of CCR2, thereby inhibiting CCR2-mediated monocyte chemotaxis toward MCP-1.","method":"VSMC conditioned media experiments, TLR4 blockade, JNK inhibitor SP600125, monocyte LDL-R and CCR2 flow cytometry, chemotaxis assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological pathway dissection with functional migration readout; single lab","pmids":["28232185"],"is_preprint":false},{"year":2017,"finding":"NOX4 in hepatic stellate cells stabilizes CCR2 and CCL2 mRNA by phosphorylating HuR at Ser221, causing its cytoplasmic shuttling; HSC-specific NOX4 knockout reduces CCR2 and CCL2 expression and inflammatory cell recruitment in alcoholic liver injury.","method":"HSC-specific NOX4 knockout mice, mRNA half-life assay, HuR phospho-immunoblot, cytoplasmic fractionation, qRT-PCR","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — cell-specific genetic KO plus mechanistic HuR phosphorylation/localization data; single lab","pmids":["28383062"],"is_preprint":false},{"year":2019,"finding":"Tissue-resident CCR2+ cardiac macrophages promote monocyte recruitment through a MyD88-dependent mechanism resulting in release of monocyte chemoattractant proteins and monocyte mobilization; tissue-resident CCR2- cardiac macrophages inhibit monocyte recruitment. Selective depletion of either subset has divergent effects on cardiac function and remodeling after MI.","method":"Syngeneic cardiac transplantation, intravital 2-photon microscopy, CCR2-DTR and CD169-DTR depletion models, single-cell RNA sequencing, MyD88 genetic analysis","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — in vivo intravital imaging, selective depletion genetics, and scRNA-seq; multiple orthogonal approaches","pmids":["30582448"],"is_preprint":false},{"year":2019,"finding":"Molecular dynamics simulations coupled with Markov-state modeling show that an orthosteric and an allosteric CCR2 antagonist each shift CCR2 into distinct stable inactive conformations, disrupting a continuous internal water and sodium ion pathway that is required for transitions to the active state; apo simulations reveal intermediate conformations along the activation pathway.","method":"Long-timescale molecular dynamics, Markov-state model analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Low","confidence_rationale":"Tier 4 — computational only, no experimental validation in this study","pmids":["30975755"],"is_preprint":false},{"year":2019,"finding":"PSMP (PC3-secreted microprotein) binds CCR2 and promotes liver fibrosis through CCR2-dependent inflammatory macrophage infiltration and hepatic stellate cell activation; AAV8-mediated PSMP overexpression in Psmp-/- livers rescues fibrosis only in a CCR2-dependent manner, and a PSMP-neutralizing antibody prevents injury.","method":"Psmp-/- mice, AAV8 overexpression rescue, CCR2-dependence test (CCR2 pathway), in vitro macrophage polarization and LX-2 activation assay, anti-PSMP antibody treatment","journal":"Journal of hepatology","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout plus rescue experiment plus antibody blockade; multiple in vivo and in vitro approaches","pmids":["31813573"],"is_preprint":false},{"year":2021,"finding":"CCR2 signaling in monocytes is required for their differentiation into macrophages within the vasculature during glomerulonephritis; mechanistically, CCR2 in circulating cells cooperates with TNFR2 in parenchymal cells—TNF-TNFR2-activated endothelial cells generate CCR2 ligands that drive CCR2-dependent monocyte differentiation, establishing a feed-forward autocrine loop. scRNA-seq defined a CCR2-dependent monocyte differentiation path associated with immune effector function acquisition.","method":"Flow cytometry of nephritic kidneys, CCR2-deficient monocyte analysis, in vitro monocyte-endothelial cell coculture, scRNA-seq, human lupus nephritis urine analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function, reconstitution in vitro, scRNA-seq mechanistic pathway definition; multiple orthogonal methods","pmids":["35404389"],"is_preprint":false},{"year":2021,"finding":"CCR2 signaling promotes classical monocyte infiltration into the lung and expansion of monocyte-derived cells during SARS-CoV-2 infection; CCR2-/- mice show higher viral loads, increased lung viral dissemination, and elevated inflammatory cytokines, demonstrating that the CCR2-monocyte axis restricts viral burden.","method":"Mouse-adapted SARS-CoV-2 infection model, CCR2-/- mice, intravital antibody labeling, scRNA-seq, flow cytometry","journal":"mBio","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with defined viral and immunological phenotypes, scRNA-seq; single lab","pmids":["34749524"],"is_preprint":false},{"year":2021,"finding":"CCR2 signaling in cancer (breast) cells suppresses the adaptive immune response: Ccr2 deletion in cancer cells increased infiltration and activation of cytotoxic T lymphocytes and CD103+ cross-presenting DCs, upregulated MHC-I, and downregulated PD-L1; effects were CD103+ DC-dependent as shown in Batf3-/- mice.","method":"Orthotopic isograft mouse model, CRISPR Ccr2 deletion, flow cytometry, pharmacological CCR2 inhibition, Batf3-/- epistasis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — genetic deletion + pharmacological + epistasis in vivo; multiple orthogonal approaches, rigorous controls","pmids":["32667673"],"is_preprint":false},{"year":2022,"finding":"Cryo-EM structure of the CCL2-CCR2-Gα-protein complex reveals that CCL2 inserts deeply into the extracellular half of the CCR2 transmembrane domain with the most N-terminal glutamine forming critical interactions; intracellular loop 2 interactions are more critical for G-protein activation than intracellular loop 3 interactions, and extensive hydrophobic/polar interactions with Gα contribute to constitutive receptor activity.","method":"Cryo-electron microscopy structure determination, functional experiments (mutagenesis of ICL2/ICL3 residues validated by signaling assay)","journal":"Cell discovery","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structure with functional mutagenesis validation; high-resolution mechanistic insight","pmids":["35570218"],"is_preprint":false},{"year":2023,"finding":"CCR2 acts as a dual-function receptor: it drives monocyte chemotaxis (G protein-dependent) AND scavenges CCL2 by constitutive internalization and recycling to the cell surface. The scavenging function is mechanistically distinct from classical GPCR desensitization—it occurs independently of G proteins, GRKs, β-arrestins, and clathrin, unlike professional scavenger receptors.","method":"CRISPR knockout cell lines (G protein, GRK, β-arrestin, clathrin), CCL2 scavenging assay, receptor recycling assay","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 2 — systematic CRISPR-KO of all candidate pathway components with quantitative scavenging and recycling readouts; rigorous mechanistic dissection","pmids":["36719944"],"is_preprint":false},{"year":2023,"finding":"Human autosomal recessive complete CCR2 deficiency causes pulmonary alveolar proteinosis and polycystic lung disease; loss-of-function CCR2 variants abolish CCL2-stimulated Ca2+ signaling and monocyte migration, resulting in approximately half the normal alveolar macrophage count due to impaired CCL2-dependent monocyte migration to the lung.","method":"Human genetics (homozygous and compound heterozygous patients), Ca2+ flux assay, monocyte migration assay, alveolar macrophage quantification","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 — human loss-of-function genetics validated by functional Ca2+ signaling and migration assays; five independent kindreds","pmids":["38157855"],"is_preprint":false},{"year":2021,"finding":"Peripheral CCL2-CCR2 signaling in macrophages and T cells (but not TG neurons) is required for chronic headache sensitization; CCR2 deletion in myeloid cells or T cells individually abolished NTG-induced facial hypersensitivity, and CCR2 signaling was mechanistically linked to enhanced CGRP and PACAP production in TG neurons.","method":"Global and cell-type-specific Ccr2 knockout mice, conditional deletion, CCL2 neutralizing antibody, behavioral testing, CGRP/PACAP measurement","journal":"Brain: a journal of neurology","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific genetic deletion with rigorous behavioral and molecular phenotypes; multiple conditional knockouts","pmids":["37284790"],"is_preprint":false}],"current_model":"CCR2 is a Gαi-coupled seven-transmembrane chemokine receptor that binds CCL2 (MCP-1) and related ligands (CCL7, CCL8, CYTL1, beta-defensins, PSMP) with high affinity—as revealed by its cryo-EM structure showing deep CCL2 insertion into the transmembrane domain and ICL2-dominant G-protein coupling—mediating monocyte/macrophage mobilization from bone marrow and recruitment to inflamed tissues; it also functions as a constitutive CCL2 scavenger receptor through a G protein/GRK/β-arrestin/clathrin-independent internalization-recycling cycle, forms hetero-oligomers with CCR5 and CXCR4 that produce cross-inhibitory signaling, engages an intracellular allosteric binding site targetable by small-molecule antagonists, and regulates downstream signaling through dynamin-dependent ERK1/2 activation and filamin A phosphorylation-dependent endosomal recycling, with its mRNA stability controlled by LPS-induced deadenylation/degradation and by NOX4-mediated HuR phosphorylation."},"narrative":{"teleology":[{"year":1994,"claim":"Molecular cloning of CCR2 as the MCP-1 receptor resolved the identity of the GPCR mediating monocyte chemotaxis to CCL2 and revealed two C-terminal splice isoforms (CCR2A/B).","evidence":"cDNA cloning with heterologous expression in Xenopus oocytes demonstrating ligand-selective calcium flux","pmids":["8146186"],"confidence":"High","gaps":["Relative signaling properties of CCR2A vs CCR2B isoforms not resolved","Endogenous ligand repertoire beyond MCP-1 unknown"]},{"year":2001,"claim":"Discovery that CCR2 and CCR5 heterodimerize and that eotaxin functions as a natural CCR2 antagonist established that CCR2 signaling is modulated by receptor oligomerization and non-cognate ligands, producing qualitatively distinct outputs (Gq/11-coupled adhesion vs. Gi-coupled chemotaxis).","evidence":"Co-immunoprecipitation, BRET, pertussis toxin-resistant Ca²⁺ flux for heterodimers; radioligand displacement and chemotaxis blockade for eotaxin antagonism","pmids":["11350939","11264152"],"confidence":"High","gaps":["Stoichiometry of heterodimeric complexes undefined","Structural basis of Gq/11 coupling by heterodimers not determined"]},{"year":2007,"claim":"Genetic loss-of-function studies in mice established that CCR2 is cell-autonomously required for monocyte egress from bone marrow and tissue recruitment, identifying MCP-1 and MCP-3 as the critical in vivo agonists maintaining circulating monocyte counts.","evidence":"CCR2−/− mice with adoptive transfer of labeled monocytes into wild-type hosts; MCP ligand knockout comparisons","pmids":["17364026"],"confidence":"High","gaps":["Relative contributions of individual CCR2 ligands in specific tissues not fully parsed","Mechanism of CCR2-dependent bone marrow release not molecularly defined"]},{"year":2009,"claim":"Identification of CCR2/CCR5/CXCR4 hetero-oligomeric complexes with negative binding cooperativity explained how selective CCR2 antagonists can cross-inhibit CXCR4 function, expanding the pharmacological consequences of receptor oligomerization.","evidence":"Bimolecular luminescence complementation and BRET in transfected cells; radioligand cooperativity in primary leukocytes; in vivo air-pouch recruitment model","pmids":["19758998"],"confidence":"High","gaps":["Native oligomer composition in tissues not determined","Structural basis of allosteric cooperativity between protomers unknown"]},{"year":2009,"claim":"Dynamin-dependent endocytosis was linked to CCR2 signal propagation: dynamin inhibition blocked both CCR2 internalization and ERK1/2 activation, while FROUNT was identified as a CCR2 C-tail interactor that focuses pseudopod formation during chemotaxis.","evidence":"Dynasore treatment and clathrin RNAi with phospho-ERK readout; FROUNT co-IP with live-cell pseudopod quantification","pmids":["19643177","19841162"],"confidence":"Medium","gaps":["Whether FROUNT acts downstream of dynamin-dependent endocytosis not tested","Endosomal signaling compartment identity not resolved"]},{"year":2014,"claim":"Mutagenesis of chimeric CCR2/CCR5 receptors revealed an intracellular allosteric binding site (NPxxYx₅₆F motif, helix VIII) for small-molecule antagonists, establishing a second druggable pocket distinct from the orthosteric chemokine-binding site.","evidence":"Chimeric receptor approach with systematic site-directed mutagenesis and radioligand binding/IP1 functional assays","pmids":["25024169"],"confidence":"High","gaps":["No crystal/cryo-EM structure of intracellular allosteric site at time of discovery","Coupling between orthosteric and allosteric sites not biophysically resolved"]},{"year":2016,"claim":"Identification of CYTL1 as a Gi-coupled CCR2B agonist and filamin A as a regulator of CCR2B endosomal recycling expanded the ligand repertoire and defined post-endocytic trafficking control via FLNa S2152 phosphorylation.","evidence":"CYTL1 binding/internalization/chemotaxis with Ccr2−/− validation; FLNa siRNA with super-resolution imaging and FRAP","pmids":["27084102","27909248"],"confidence":"Medium","gaps":["Physiological concentration of CYTL1 at tissue level not established","Kinase responsible for FLNa S2152 phosphorylation downstream of CCR2 not identified"]},{"year":2022,"claim":"The cryo-EM structure of CCL2–CCR2–Gαi resolved the molecular basis of ligand recognition and G-protein coupling, showing deep CCL2 N-terminal insertion into the TM bundle and a dominant role for ICL2 over ICL3 in Gα engagement.","evidence":"Cryo-EM structure determination with mutagenesis validation of ICL2/ICL3 residues by signaling assay","pmids":["35570218"],"confidence":"High","gaps":["Structure of CCR2 bound to alternative ligands (CYTL1, defensins, PSMP) not available","Active-state structure without Gα not resolved"]},{"year":2023,"claim":"Systematic CRISPR knockout of canonical GPCR trafficking components demonstrated that CCR2 constitutively scavenges CCL2 through a mechanistically novel pathway independent of G proteins, GRKs, β-arrestins, and clathrin, separating scavenging from signaling functions.","evidence":"CRISPR KO of G protein, GRK, β-arrestin, and clathrin subunits with quantitative CCL2 scavenging and receptor recycling assays","pmids":["36719944"],"confidence":"High","gaps":["Molecular machinery mediating G protein-independent internalization and recycling not identified","Physiological importance of scavenging vs signaling in tissue homeostasis not quantified"]},{"year":2023,"claim":"Human autosomal recessive CCR2 deficiency was shown to cause pulmonary alveolar proteinosis and polycystic lung disease, directly linking CCR2 loss-of-function to failed alveolar macrophage homeostasis via impaired monocyte migration.","evidence":"Five independent kindreds with homozygous/compound heterozygous loss-of-function variants; Ca²⁺ flux and monocyte migration assays confirming abolished signaling","pmids":["38157855"],"confidence":"High","gaps":["Whether CCR2 deficiency also causes susceptibility to infections or other immune phenotypes in humans not yet systematically studied","Genotype–phenotype correlation across different mutation types not established"]},{"year":null,"claim":"Key unresolved questions include the molecular identity of the scavenging internalization machinery, the structural basis of heterodimer-specific G-protein coupling, and whether the intracellular allosteric site can be therapeutically exploited independently of orthosteric blockade.","evidence":"","pmids":[],"confidence":"Low","gaps":["Scavenging internalization machinery completely unknown","No structure of CCR2/CCR5 heterodimer","Clinical utility of intracellular allosteric antagonists untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,20,29,31]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[30]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[6,12]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,2,3,19,29]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[14,19]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[14,30]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10,23,26,27,28,31]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,6,14,17,20,29]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[25,28,31]}],"complexes":["CCR2/CCR5 heterodimer","CCR2/CCR5/CXCR4 hetero-oligomer"],"partners":["CCR5","CXCR4","FLNA","TNPO1","FROUNT","CCL2","CYTL1"],"other_free_text":[]},"mechanistic_narrative":"CCR2 is a Gαi-coupled seven-transmembrane chemokine receptor that serves as the principal mediator of monocyte/macrophage mobilization from bone marrow and recruitment to inflamed tissues in response to CCL2 (MCP-1) and additional ligands including CCL7, CYTL1, beta-defensins, and PSMP [PMID:8146186, PMID:17364026, PMID:27084102, PMID:20483750, PMID:31813573]. Beyond classical chemotaxis, CCR2 functions as a constitutive CCL2 scavenger receptor through a G protein-, GRK-, β-arrestin-, and clathrin-independent internalization–recycling cycle, and forms hetero-oligomeric complexes with CCR5 and CXCR4 that produce cross-inhibitory binding cooperativity and qualitatively distinct signaling outputs including Gq/11-coupled cell adhesion [PMID:36719944, PMID:11350939, PMID:19758998]. The cryo-EM structure of the CCL2–CCR2–Gα complex reveals deep CCL2 insertion into the transmembrane domain and a dominant role for intracellular loop 2 in G-protein coupling, while mutagenesis has defined a pharmacologically targetable intracellular allosteric site within the NPxxYx₅₆F motif [PMID:35570218, PMID:25024169]. Autosomal recessive loss-of-function CCR2 mutations in humans cause pulmonary alveolar proteinosis and polycystic lung disease due to impaired monocyte migration and reduced alveolar macrophage numbers [PMID:38157855]."},"prefetch_data":{"uniprot":{"accession":"P41597","full_name":"C-C chemokine receptor type 2","aliases":["Monocyte chemoattractant protein 1 receptor","MCP-1-R"],"length_aa":374,"mass_kda":41.9,"function":"Key functional receptor for CCL2 but can also bind CCL7, and CCL12 (PubMed:23408426, PubMed:38157855, PubMed:8048929, PubMed:8146186). Also transduces signaling mediated by CCL13 (PubMed:38157855). Its binding with CCL2 on monocytes and macrophages mediates chemotaxis and migration induction through the activation of the PI3K cascade, the small G protein Rac and lamellipodium protrusion (PubMed:38157855). Also acts as a receptor for the beta-defensin DEFB106A/DEFB106B (PubMed:23938203). Regulates the expression of T-cell inflammatory cytokines and T-cell differentiation, promoting the differentiation of T-cells into T-helper 17 cells (Th17) during inflammation (By similarity). Facilitates the export of mature thymocytes by enhancing directional movement of thymocytes to sphingosine-1-phosphate stimulation and up-regulation of S1P1R expression; signals through the JAK-STAT pathway to regulate FOXO1 activity leading to an increased expression of S1P1R (By similarity). Plays an important role in mediating peripheral nerve injury-induced neuropathic pain (By similarity). Increases NMDA-mediated synaptic transmission in both dopamine D1 and D2 receptor-containing neurons, which may be caused by MAPK/ERK-dependent phosphorylation of GRIN2B/NMDAR2B (By similarity). Mediates the recruitment of macrophages and monocytes to the injury site following brain injury (By similarity) (Microbial infection) Alternative coreceptor with CD4 for HIV-1 infection","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P41597/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CCR2","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CCR2","total_profiled":1310},"omim":[{"mim_id":"620874","title":"ADHESION G PROTEIN-COUPLED RECEPTOR F5; ADGRF5","url":"https://www.omim.org/entry/620874"},{"mim_id":"612007","title":"CELIAC DISEASE, SUSCEPTIBILITY TO, 9; CELIAC9","url":"https://www.omim.org/entry/612007"},{"mim_id":"611775","title":"KAWASAKI DISEASE","url":"https://www.omim.org/entry/611775"},{"mim_id":"610379","title":"WEST NILE VIRUS, SUSCEPTIBILITY TO","url":"https://www.omim.org/entry/610379"},{"mim_id":"609532","title":"HEPATITIS C VIRUS, SUSCEPTIBILITY TO","url":"https://www.omim.org/entry/609532"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Nucleoli fibrillar center","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":23.1}],"url":"https://www.proteinatlas.org/search/CCR2"},"hgnc":{"alias_symbol":["CC-CKR-2","CKR2","MCP-1-R","CD192","FLJ78302"],"prev_symbol":["CMKBR2"]},"alphafold":{"accession":"P41597","domains":[{"cath_id":"1.20.1070.10","chopping":"36-322","consensus_level":"medium","plddt":89.0476,"start":36,"end":322}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P41597","model_url":"https://alphafold.ebi.ac.uk/files/AF-P41597-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P41597-F1-predicted_aligned_error_v6.png","plddt_mean":77.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CCR2","jax_strain_url":"https://www.jax.org/strain/search?query=CCR2"},"sequence":{"accession":"P41597","fasta_url":"https://rest.uniprot.org/uniprotkb/P41597.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P41597/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P41597"}},"corpus_meta":[{"pmid":"30582448","id":"PMC_30582448","title":"Tissue Resident CCR2- and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury.","date":"2019","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/30582448","citation_count":591,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26885690","id":"PMC_26885690","title":"Targeting the CCL2-CCR2 signaling axis in cancer metastasis.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26885690","citation_count":410,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32471499","id":"PMC_32471499","title":"CCL2/CCR2 signaling in cancer pathogenesis.","date":"2020","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/32471499","citation_count":259,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25957903","id":"PMC_25957903","title":"Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells.","date":"2015","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/25957903","citation_count":187,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23771498","id":"PMC_23771498","title":"Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.","date":"2013","source":"Archives of pharmacal research","url":"https://pubmed.ncbi.nlm.nih.gov/23771498","citation_count":177,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29861387","id":"PMC_29861387","title":"Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis.","date":"2018","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/29861387","citation_count":156,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20354109","id":"PMC_20354109","title":"Multiple roles for CCR2 during fracture healing.","date":"2010","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/20354109","citation_count":152,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11264152","id":"PMC_11264152","title":"Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5.","date":"2001","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11264152","citation_count":150,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24806994","id":"PMC_24806994","title":"CCR2 deficiency impairs macrophage infiltration and improves cognitive function after traumatic brain injury.","date":"2014","source":"Journal of neurotrauma","url":"https://pubmed.ncbi.nlm.nih.gov/24806994","citation_count":150,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19441905","id":"PMC_19441905","title":"Recent developments in CCR2 antagonists.","date":"2009","source":"Expert opinion on therapeutic patents","url":"https://pubmed.ncbi.nlm.nih.gov/19441905","citation_count":148,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20554025","id":"PMC_20554025","title":"Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS.","date":"2010","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/20554025","citation_count":147,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29572892","id":"PMC_29572892","title":"Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2.","date":"2018","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/29572892","citation_count":140,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19758998","id":"PMC_19758998","title":"Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of \"selective\" antagonists.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19758998","citation_count":140,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27536731","id":"PMC_27536731","title":"Heart-resident CCR2+ macrophages promote neutrophil extravasation through TLR9/MyD88/CXCL5 signaling.","date":"2016","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/27536731","citation_count":139,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15601671","id":"PMC_15601671","title":"Chemokine receptor CCR2 involvement in skeletal muscle regeneration.","date":"2004","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/15601671","citation_count":138,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35567558","id":"PMC_35567558","title":"Targeting the CCL2-CCR2 axis for atheroprotection.","date":"2022","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/35567558","citation_count":137,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24984897","id":"PMC_24984897","title":"Role of CCR2 in inflammatory conditions of the central nervous system.","date":"2014","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24984897","citation_count":132,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28566450","id":"PMC_28566450","title":"Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease.","date":"2017","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/28566450","citation_count":129,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29743615","id":"PMC_29743615","title":"Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel disease.","date":"2018","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29743615","citation_count":127,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24950695","id":"PMC_24950695","title":"Silencing of CCR2 in myocarditis.","date":"2014","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/24950695","citation_count":122,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12507897","id":"PMC_12507897","title":"Experimental autoimmune encephalomyelitis (EAE) in CCR2(-/-) mice: susceptibility in multiple strains.","date":"2003","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12507897","citation_count":112,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34445235","id":"PMC_34445235","title":"Roles of CCL2-CCR2 Axis in the Tumor Microenvironment.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34445235","citation_count":109,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21880831","id":"PMC_21880831","title":"Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury.","date":"2011","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21880831","citation_count":105,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31377844","id":"PMC_31377844","title":"Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders.","date":"2019","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/31377844","citation_count":104,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35281057","id":"PMC_35281057","title":"Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35281057","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36950739","id":"PMC_36950739","title":"M2 Macrophage-Derived sEV Regulate Pro-Inflammatory CCR2+ Macrophage Subpopulations to Favor Post-AMI Cardiac Repair.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/36950739","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17763443","id":"PMC_17763443","title":"Targeting of Gr-1+,CCR2+ monocytes in collagen-induced arthritis.","date":"2007","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/17763443","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20360402","id":"PMC_20360402","title":"Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases.","date":"2010","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/20360402","citation_count":92,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19002595","id":"PMC_19002595","title":"Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone.","date":"2008","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/19002595","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28025034","id":"PMC_28025034","title":"CCL2/CCR2 signaling pathway in glioblastoma multiforme.","date":"2016","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/28025034","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23986513","id":"PMC_23986513","title":"CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice.","date":"2013","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23986513","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20536421","id":"PMC_20536421","title":"CCR2 antagonists.","date":"2010","source":"Current topics in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20536421","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35570218","id":"PMC_35570218","title":"Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3.","date":"2022","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/35570218","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12954060","id":"PMC_12954060","title":"CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach.","date":"2003","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12954060","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26205994","id":"PMC_26205994","title":"CCL2 and CCR2 are Essential for the Formation of Osteoclasts and Foreign Body Giant Cells.","date":"2016","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26205994","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25312961","id":"PMC_25312961","title":"The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion.","date":"2014","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/25312961","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15257681","id":"PMC_15257681","title":"Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis.","date":"2004","source":"European journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15257681","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20180766","id":"PMC_20180766","title":"Targeting the MCP-1/CCR2 System in diabetic kidney disease.","date":"2010","source":"Current vascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20180766","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27852031","id":"PMC_27852031","title":"Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27852031","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25271254","id":"PMC_25271254","title":"The chemokine receptors ACKR2 and CCR2 reciprocally regulate lymphatic vessel density.","date":"2014","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/25271254","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30472461","id":"PMC_30472461","title":"Role of MCP-1 and CCR2 in alcohol neurotoxicity.","date":"2018","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/30472461","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28168553","id":"PMC_28168553","title":"CCR2 contributes to the recruitment of monocytes and leads to kidney inflammation and fibrosis development.","date":"2017","source":"Inflammopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28168553","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31813573","id":"PMC_31813573","title":"PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target.","date":"2019","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/31813573","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35404389","id":"PMC_35404389","title":"Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2.","date":"2022","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35404389","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34749524","id":"PMC_34749524","title":"CCR2 Signaling Restricts SARS-CoV-2 Infection.","date":"2021","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/34749524","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34162553","id":"PMC_34162553","title":"The CCL2-CCR2 astrocyte-cancer cell axis in tumor extravasation at the brain.","date":"2021","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/34162553","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21143971","id":"PMC_21143971","title":"Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain.","date":"2010","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/21143971","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9971830","id":"PMC_9971830","title":"CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function.","date":"1999","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/9971830","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20197192","id":"PMC_20197192","title":"Systemic MCP1/CCR2 blockade and leukocyte specific MCP1/CCR2 inhibition affect aortic aneurysm formation differently.","date":"2010","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/20197192","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10400139","id":"PMC_10400139","title":"Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus.","date":"1999","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/10400139","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31666087","id":"PMC_31666087","title":"MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology.","date":"2019","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/31666087","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16095529","id":"PMC_16095529","title":"A role for MCP-1/CCR2 in interstitial lung disease in children.","date":"2005","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/16095529","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32667673","id":"PMC_32667673","title":"Cancer cell CCR2 orchestrates suppression of the adaptive immune response.","date":"2020","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32667673","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30276825","id":"PMC_30276825","title":"CAD1 and CCR2 protein complex formation in monolignol biosynthesis in Populus trichocarpa.","date":"2018","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/30276825","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15020650","id":"PMC_15020650","title":"MCP-1-dependent signaling in CCR2(-/-) aortic smooth muscle cells.","date":"2004","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/15020650","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29352000","id":"PMC_29352000","title":"Mesenchymal Stem Cells Recruit CCR2+ Monocytes To Suppress Allergic Airway Inflammation.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/29352000","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9365120","id":"PMC_9365120","title":"Regulation of CCR2 chemokine receptor mRNA stability.","date":"1997","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/9365120","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31439648","id":"PMC_31439648","title":"Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy.","date":"2019","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/31439648","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35026420","id":"PMC_35026420","title":"Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition.","date":"2022","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/35026420","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28232185","id":"PMC_28232185","title":"PCSK9 regulates the chemokine receptor CCR2 on monocytes.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28232185","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29791797","id":"PMC_29791797","title":"Modulating Macrophage Polarization through CCR2 Inhibition and Multivalent Engagement.","date":"2018","source":"Molecular pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/29791797","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25024169","id":"PMC_25024169","title":"Discovery and mapping of an intracellular antagonist binding site at the chemokine receptor CCR2.","date":"2014","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25024169","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38157855","id":"PMC_38157855","title":"Human inherited CCR2 deficiency underlies progressive polycystic lung disease.","date":"2023","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/38157855","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16518346","id":"PMC_16518346","title":"The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells.","date":"2006","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/16518346","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31672939","id":"PMC_31672939","title":"Salt increases monocyte CCR2 expression and inflammatory responses in humans.","date":"2019","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/31672939","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27831552","id":"PMC_27831552","title":"Knockout of Ccr2 alleviates photoreceptor cell death in rodent retina exposed to chronic blue light.","date":"2016","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/27831552","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28450294","id":"PMC_28450294","title":"Gas6 Promotes Inflammatory (CCR2hiCX3CR1lo) Monocyte Recruitment in Venous Thrombosis.","date":"2017","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28450294","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35185928","id":"PMC_35185928","title":"CCR2+ Macrophages Promote Orthodontic Tooth Movement and Alveolar Bone Remodeling.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35185928","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26647393","id":"PMC_26647393","title":"A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo.","date":"2015","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/26647393","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19841162","id":"PMC_19841162","title":"FROUNT is a common regulator of CCR2 and CCR5 signaling to control directional migration.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19841162","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33011241","id":"PMC_33011241","title":"CCR2-targeted micelles for anti-cancer peptide delivery and immune stimulation.","date":"2020","source":"Journal of controlled release : official journal of the Controlled Release Society","url":"https://pubmed.ncbi.nlm.nih.gov/33011241","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19643177","id":"PMC_19643177","title":"Inhibition of dynamin prevents CCL2-mediated endocytosis of CCR2 and activation of ERK1/2.","date":"2009","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/19643177","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27084102","id":"PMC_27084102","title":"Cytokine-like 1 Chemoattracts Monocytes/Macrophages via CCR2.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27084102","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34031863","id":"PMC_34031863","title":"Targeting the CCL2-CCR2 axis in depressive disorders.","date":"2021","source":"Pharmacological reports : PR","url":"https://pubmed.ncbi.nlm.nih.gov/34031863","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30975755","id":"PMC_30975755","title":"Structural basis for ligand modulation of the CCR2 conformational landscape.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30975755","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34311579","id":"PMC_34311579","title":"CCR2 Signaling Promotes Brain Infiltration of Inflammatory Monocytes and Contributes to Neuropathology during Cryptococcal Meningoencephalitis.","date":"2021","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/34311579","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33519816","id":"PMC_33519816","title":"CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33519816","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36719944","id":"PMC_36719944","title":"The dual-function chemokine receptor CCR2 drives migration and chemokine scavenging through distinct mechanisms.","date":"2023","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/36719944","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26458944","id":"PMC_26458944","title":"Expression pattern of Ccr2 and Cx3cr1 in inherited retinal degeneration.","date":"2015","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/26458944","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10710532","id":"PMC_10710532","title":"MCP-1 in pleural injury: CCR2 mediates haptotaxis of pleural mesothelial cells.","date":"2000","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10710532","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38284280","id":"PMC_38284280","title":"CCL2-CCR2 signaling axis in obesity and metabolic diseases.","date":"2024","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/38284280","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35013585","id":"PMC_35013585","title":"CCR2 promotes monocyte recruitment and intestinal inflammation in mice lacking the interleukin-10 receptor.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35013585","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18846510","id":"PMC_18846510","title":"Chemokine receptor CCR2 undergoes transportin1-dependent nuclear translocation.","date":"2008","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/18846510","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36434305","id":"PMC_36434305","title":"Activin A and CCR2 regulate macrophage function in testicular fibrosis caused by experimental autoimmune orchitis.","date":"2022","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/36434305","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33313981","id":"PMC_33313981","title":"Kidney inflammaging is promoted by CCR2+ macrophages and tissue-derived micro-environmental factors.","date":"2020","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/33313981","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37284790","id":"PMC_37284790","title":"Peripheral CCL2-CCR2 signalling contributes to chronic headache-related sensitization.","date":"2023","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37284790","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23632061","id":"PMC_23632061","title":"CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.","date":"2013","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23632061","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17888174","id":"PMC_17888174","title":"Alveolar macrophages lack CCR2 expression and do not migrate to CCL2.","date":"2007","source":"Journal of inflammation (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17888174","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38564300","id":"PMC_38564300","title":"NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy.","date":"2024","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/38564300","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33971183","id":"PMC_33971183","title":"B cells modulate the expression of MHC-II on cardiac CCR2- macrophages.","date":"2021","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/33971183","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35327464","id":"PMC_35327464","title":"Role of CCR2-Positive Macrophages in Pathological Ventricular Remodelling.","date":"2022","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/35327464","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12680626","id":"PMC_12680626","title":"CCR5 and CCR2 gene polymorphisms in hypertensive patients.","date":"2003","source":"British journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/12680626","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28768911","id":"PMC_28768911","title":"A CCR2+ myeloid cell niche required for pancreatic β cell growth.","date":"2017","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/28768911","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16466022","id":"PMC_16466022","title":"Isolation and structures of novel fungal metabolites as chemokine receptor (CCR2) antagonists.","date":"2005","source":"The Journal of antibiotics","url":"https://pubmed.ncbi.nlm.nih.gov/16466022","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11377705","id":"PMC_11377705","title":"Polymorphism of CC chemokine receptors CCR2 and CCR5 in Crohn's disease.","date":"2001","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/11377705","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28698550","id":"PMC_28698550","title":"The PSMP-CCR2 interactions trigger monocyte/macrophage-dependent colitis.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28698550","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11282297","id":"PMC_11282297","title":"Ligands for peroxisome proliferator-activated receptor inhibit monocyte CCR2 expression stimulated by plasma lipoproteins.","date":"2000","source":"Trends in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11282297","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34191381","id":"PMC_34191381","title":"Immune status of decidual macrophages is dependent on the CCL2/CCR2/JAK2 pathway during early pregnancy.","date":"2021","source":"American journal of reproductive immunology (New York, N.Y. : 1989)","url":"https://pubmed.ncbi.nlm.nih.gov/34191381","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28383062","id":"PMC_28383062","title":"NOX4 Regulates CCR2 and CCL2 mRNA Stability in Alcoholic Liver Disease.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28383062","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27909248","id":"PMC_27909248","title":"Phosphorylation of filamin A regulates chemokine receptor CCR2 recycling.","date":"2016","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/27909248","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11181995","id":"PMC_11181995","title":"The sequence of the human genome.","date":"2001","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11181995","citation_count":8428,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17364026","id":"PMC_17364026","title":"Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites.","date":"2007","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/17364026","citation_count":945,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20190752","id":"PMC_20190752","title":"Multiple common variants for celiac disease influencing immune gene expression.","date":"2010","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20190752","citation_count":801,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9252328","id":"PMC_9252328","title":"Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.","date":"1997","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9252328","citation_count":725,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24906148","id":"PMC_24906148","title":"Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/24906148","citation_count":717,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27055731","id":"PMC_27055731","title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.","date":"2016","source":"The Lancet. Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27055731","citation_count":654,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8146186","id":"PMC_8146186","title":"Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8146186","citation_count":639,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12149192","id":"PMC_12149192","title":"Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12149192","citation_count":454,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20842059","id":"PMC_20842059","title":"Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b.","date":"2010","source":"Journal of immunotherapy (Hagerstown, Md. : 1997)","url":"https://pubmed.ncbi.nlm.nih.gov/20842059","citation_count":434,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24639350","id":"PMC_24639350","title":"CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24639350","citation_count":408,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19904283","id":"PMC_19904283","title":"Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.","date":"2009","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19904283","citation_count":370,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32103760","id":"PMC_32103760","title":"CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.","date":"2020","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32103760","citation_count":357,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11350939","id":"PMC_11350939","title":"Chemokine receptor homo- or heterodimerization activates distinct signaling pathways.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11350939","citation_count":351,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20681057","id":"PMC_20681057","title":"The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases.","date":"2010","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/20681057","citation_count":338,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9182688","id":"PMC_9182688","title":"Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes.","date":"1997","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9182688","citation_count":329,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23251661","id":"PMC_23251661","title":"Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23251661","citation_count":312,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17295203","id":"PMC_17295203","title":"Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.","date":"2007","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17295203","citation_count":289,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9662369","id":"PMC_9662369","title":"Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression.","date":"1998","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9662369","citation_count":281,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11500196","id":"PMC_11500196","title":"Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients.","date":"2001","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/11500196","citation_count":264,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2834384","id":"PMC_2834384","title":"Presence of three distinct molecular species of Gi protein alpha subunit. Structure of rat cDNAs and human genomic DNAs.","date":"1988","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2834384","citation_count":256,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10479649","id":"PMC_10479649","title":"Expression of CCR2 by endothelial cells : implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium.","date":"1999","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10479649","citation_count":254,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11694103","id":"PMC_11694103","title":"Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.","date":"2001","source":"Annals of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11694103","citation_count":254,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12374865","id":"PMC_12374865","title":"HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12374865","citation_count":242,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20483750","id":"PMC_20483750","title":"Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20483750","citation_count":237,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48843,"output_tokens":7790,"usd":0.131689},"stage2":{"model":"claude-opus-4-6","input_tokens":11596,"output_tokens":3118,"usd":0.203895},"total_usd":0.697423,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":64821,"output_tokens":8099,"usd":0.157974},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":12122,"output_tokens":3012,"usd":0.203865}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2022,\n      \"finding\": \"Cryo-EM structure of the CCL2-CCR2-G-protein complex reveals that CCL2 inserts deeply into the extracellular half of the transmembrane domain, forming substantial interactions through the most N-terminal glutamine of CCL2; intracellular loop 2 interactions are conserved and play a more critical role in G-protein activation than those around intracellular loop 3.\",\n      \"method\": \"Cryo-electron microscopy with functional experiments (mutagenesis)\",\n      \"journal\": \"Cell discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure with functional validation and mutagenesis\",\n      \"pmids\": [\"35570218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CCR2 possesses an allosteric intracellular antagonist binding site; key residues include the conserved tyrosine Y(7.53) and phenylalanine F(8.50) of the NPxxYx(5,6)F motif, V(6.36) at the bottom of TM-VI, and K(8.49) in helix-VIII, as identified by chimeric CCR2/CCR5 receptors and single-point mutagenesis combined with radioligand binding and IP turnover assays.\",\n      \"method\": \"Chimeric receptor approach, site-directed mutagenesis, radioligand binding assays, functional IP turnover assays\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with multiple orthogonal functional assays in a single study\",\n      \"pmids\": [\"25024169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Site-directed mutagenesis guided by a homology model of CCR2 (based on bovine rhodopsin crystal structure) defined the antagonist binding site within the transmembrane domain, consistent with docking models for indole piperidine and related antagonist series.\",\n      \"method\": \"Receptor homology modeling, site-directed mutagenesis, ligand docking\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1/2 — mutagenesis with functional validation but single lab\",\n      \"pmids\": [\"12954060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CCR2, CCR5, and CXCR4 form hetero-oligomeric complexes of at least three receptors; negative binding cooperativity occurs between their binding pockets in T cells and monocytes, and antagonists of one receptor (TAK-779, AMD3100) cause functional cross-inhibition of the others both in vitro and in vivo.\",\n      \"method\": \"Luminescence complementation, bioluminescence resonance energy transfer (BRET), radioligand binding, in vivo air pouch model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (BRET, BiLC, binding, in vivo), single study\",\n      \"pmids\": [\"19758998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Eotaxin acts as a natural antagonist for CCR2 (blocking MCP-1-induced chemotaxis and enzyme release without triggering CCR2 internalization) and as an agonist for CCR5; eotaxin displaces 125I-MCP-1 from monocytes in a concentration-dependent manner.\",\n      \"method\": \"Radioligand displacement binding, chemotaxis assays, receptor internalization assays, transfected cell lines\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal assays (binding, chemotaxis, internalization) with transfected and primary cells\",\n      \"pmids\": [\"11264152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"FROUNT binds to the C-terminal cytoplasmic region of CCR2 (and CCR5) and enhances CCR2-mediated directional chemotaxis by promoting pseudopodium formation and amplifying shallow chemokine gradients; FROUNT suppression impairs directionality of chemotaxis.\",\n      \"method\": \"Co-immunoprecipitation/binding assays, overexpression and knockdown, chemotaxis assays, live-cell imaging\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — binding and functional chemotaxis data, single lab\",\n      \"pmids\": [\"19841162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CCR2 internalizes via a combination of clathrin-dependent and clathrin-independent pathways after CCL2 binding, trafficking to early endosomes and then lysosomes; dynamin is required for internalization, and a dynamin-sensitive step also regulates ERK1/2 activation downstream of CCR2.\",\n      \"method\": \"RNA interference (clathrin knockdown), dynasore pharmacological inhibition, fluorescence microscopy, ERK1/2 phosphorylation assays\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic/pharmacological perturbations with mechanistic readouts, single lab\",\n      \"pmids\": [\"19643177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Phosphorylation of filamin A (FLNa) at S2152 by CCR2B signaling promotes endosomal recycling of CCR2B back to the plasma membrane; FLNa knockdown causes activated CCR2B to accumulate in enlarged EEA-1-positive endosomes with impaired trafficking, reducing monocyte migration.\",\n      \"method\": \"FLNa knockdown, super-resolution microscopy, phosphorylation assays, endosomal trafficking assays, FRAP\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple microscopy and biochemical methods, single lab\",\n      \"pmids\": [\"27909248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CCR2 operates as a dual-function receptor: it drives G-protein-mediated monocyte chemotaxis upon CCL2 binding, and independently scavenges CCL2 from the extracellular space by constitutive internalization and recycling; scavenging is independent of G proteins, GRKs, β-arrestins, and clathrin, distinguishing it mechanistically from other scavenger receptors.\",\n      \"method\": \"CRISPR knockout of G proteins, GRKs, β-arrestins, clathrin; CCL2 scavenging assays, internalization assays\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — rigorous CRISPR-based dissection with multiple orthogonal knockouts and functional assays\",\n      \"pmids\": [\"36719944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CCR2 undergoes transportin1 (TRN1)-dependent nuclear translocation after CCL2 stimulation; TRN1 directly interacts with CCR2, interaction increases over time in agonist-treated cells, and the receptor localizes to the outer nuclear envelope before release from TRN1.\",\n      \"method\": \"Modified CCR2 as bait (co-immunoprecipitation/proteomics), co-IP validation, fluorescence microscopy of nuclear translocation\",\n      \"journal\": \"Proteomics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, pulldown plus microscopy without extensive mechanistic follow-up\",\n      \"pmids\": [\"18846510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"LPS induces rapid degradation of CCR2 mRNA through a two-step process: deadenylation followed by degradation of the message body, as demonstrated by tracking poly(A) vs. total CCR2 RNA decay rates.\",\n      \"method\": \"mRNA stability assays, poly(A) RNA analysis, LPS stimulation of monocytes\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic dissection of deadenylation-first mRNA decay, single lab\",\n      \"pmids\": [\"9365120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CCL2 and CCR2 are both required for osteoclast and foreign body giant cell (FBGC) formation from bone marrow precursors; CCR2 knockout reduces the number and size of osteoclasts and FBGCs, and exogenous CCL2 rescues osteoclast formation in CCL2-/- but not CCR2-/- marrow cultures.\",\n      \"method\": \"CCL2-/- and CCR2-/- mouse bone marrow cultures, rescue with exogenous CCL2, cell counting and size measurement\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO plus rescue experiment in primary cells\",\n      \"pmids\": [\"26205994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CYTL1 (cytokine-like 1) is a functional ligand for CCR2B; CYTL1 signals through CCR2B via a pertussis toxin-sensitive (Gαi) ERK pathway to induce monocyte/macrophage chemotaxis, as demonstrated by receptor internalization, radioactive binding assays, and absence of chemotaxis in Ccr2-/- macrophages.\",\n      \"method\": \"Chemotaxis assays, receptor internalization assays, radioligand binding, CCR2-/- mice, pertussis toxin inhibition, ERK pathway inhibition\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal assays including binding, internalization, KO rescue, and pathway dissection\",\n      \"pmids\": [\"27084102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PSMP (PC3-secreted microprotein) signals through CCR2 to promote liver fibrosis; PSMP deficiency or overexpression in CCR2-dependent manner alters macrophage infiltration and hepatic stellate cell activation, and PSMP effects on fibrosis are reversed by CCR2-/- status or anti-PSMP antibody.\",\n      \"method\": \"Psmp-/- mice, AAV-mediated PSMP overexpression in CCR2-/- mice, in vitro macrophage polarization assays, CCR2-dependent chemotaxis assays\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO plus rescue in CCR2-/- background with multiple in vivo and in vitro readouts\",\n      \"pmids\": [\"31813573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PSMP promotes CCR2+ monocyte migration to colitis tissue in a CCR2-dependent manner; PSMP is up-regulated prior to IL-6, TNF-α, and CCL2 in DSS colitis, induces M1 macrophage polarization, and its blockade reduces colitis severity.\",\n      \"method\": \"In situ chemotaxis assays, adoptive transfer assays with Ly6Chi monocytes, PSMP neutralizing antibody, DSS colitis model\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo chemotaxis plus adoptive transfer mechanistic assays, single lab\",\n      \"pmids\": [\"28698550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CCR2 is expressed on pleural mesothelial cells and mediates haptotactic migration in response to MCP-1; IL-2 upregulates CCR2 expression and enhances haptotaxis, LPS initially downregulates CCR2 and reduces haptotaxis, and neutralizing anti-CCR2 antibodies block MCP-1-induced haptotaxis.\",\n      \"method\": \"FACS analysis, RT-PCR, neutralizing antibody blocking, haptotaxis migration assays\",\n      \"journal\": \"American journal of physiology. Lung cellular and molecular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — antibody blocking and expression studies with functional readout, single lab\",\n      \"pmids\": [\"10710532\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"MCP-1 induces tissue factor activity in arterial smooth muscle cells (SMCs) from CCR2-/- mice via an alternative MCP-1 receptor that signals through Gαi and intracellular Ca2+ mobilization, activating ERK p42/44; this activity is pertussis toxin-sensitive and PD98059-sensitive but SB203580-insensitive, demonstrating that SMCs possess a second functional MCP-1 receptor independent of CCR2.\",\n      \"method\": \"CCR2-/- mouse SMCs, pertussis toxin, BAPTA-AM, kinase inhibitors (PD98059, SB203580), ERK phosphorylation assays, tissue factor activity assay\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection in CCR2-null primary cells with multiple signaling readouts\",\n      \"pmids\": [\"15020650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CCR2 is expressed on human mesangial cells and mediates MCP-1-induced ICAM-1 upregulation and monocyte adhesion; CCR2 blockade with RS102895 prevents MCP-1-induced ICAM-1 expression, while mechanical stretch downregulates CCR2 mRNA/protein via an MCP-1-independent mechanism.\",\n      \"method\": \"CCR2 blockade (RS102895), immunofluorescence, cytofluorimetry, RT-PCR, immunoblotting, monocyte adhesion assay\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — pharmacological blockade with multiple expression and functional readouts, single lab\",\n      \"pmids\": [\"16518346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PCSK9 from LPS-stimulated vascular smooth muscle cells reduces monocyte LDL-R expression, which in turn reduces LDL-C-dependent CCR2 upregulation on monocytes, thereby inhibiting CCR2-mediated monocyte migration toward MCP-1; VSMC PCSK9 induction by LPS is mediated through TLR-4–SAPK/JNK signaling.\",\n      \"method\": \"Conditioned media transfer, recombinant PCSK9, LDL-R blocking antibody, kinase inhibitors, migration assays, flow cytometry\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple pharmacological and recombinant protein approaches with functional migration readout, single lab\",\n      \"pmids\": [\"28232185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SphK1 in hepatic stellate cells (HSCs) upregulates CCR2 expression by suppressing miR-19b-3p; miR-19b-3p directly downregulates CCR2 in HSCs, and SphK1 in Kupffer cells mediates CCL2 secretion; this dual mechanism promotes HSC activation and liver fibrosis.\",\n      \"method\": \"SphK1-/- mice, bone marrow transplantation, miRNA manipulation, CCl4/BDL fibrosis models, in vitro HSC/KC studies\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO plus BMT plus miRNA mechanistic studies, single lab\",\n      \"pmids\": [\"29572892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NOX4 in hepatic stellate cells stabilizes CCR2 and CCL2 mRNA by promoting Ser221 phosphorylation and cytoplasmic shuttling of the RNA-binding protein HuR; HSC-specific NOX4 knockout significantly reduces CCR2 and CCL2 expression in alcoholic liver injury.\",\n      \"method\": \"HSC-specific NOX4 KO mice, alcohol diet model, mRNA half-life assays, HuR phosphorylation and localization studies\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific genetic KO plus mechanistic mRNA stability studies, single lab\",\n      \"pmids\": [\"28383062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The CCR2-64I polymorphism (Val64Ile) does not exert dominant-negative activity on CCR5 coreceptor function, does not significantly alter CCR5 cell surface expression or mRNA levels, and CCR5 promoter polymorphisms linked to CCR2-64I do not affect transcriptional activity in reporter assays.\",\n      \"method\": \"Primary T cell flow cytometry, RT-PCR, transfected CCR5 promoter reporter constructs, HIV coreceptor functional assays\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods to test the specific mechanistic hypothesis, single study\",\n      \"pmids\": [\"9971830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Human complete loss-of-function CCR2 deficiency abolishes CCL2-stimulated Ca2+ signaling and monocyte migration, leads to markedly reduced alveolar macrophage counts (approximately half normal), elevated blood CCL2, and causes pulmonary alveolar proteinosis and polycystic lung disease, establishing CCL2-CCR2 as essential for monocyte migration to the lungs.\",\n      \"method\": \"Human genetics (loss-of-function variants), Ca2+ signaling assays, monocyte migration assays, bronchoalveolar lavage macrophage counts, serum CCL2 measurement\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — human genetic disease with functional validation across multiple patients and orthogonal assays\",\n      \"pmids\": [\"38157855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Monocyte CCR2 and parenchymal TNFR2 cooperate to initiate monocyte-to-macrophage differentiation within the inflamed vasculature; TNF-TNFR2-activated endothelial cells generate CCR2 ligands that drive a CCR2-dependent monocyte differentiation pathway with acquisition of immune effector functions and further CCR2 ligand production, forming a feed-forward loop.\",\n      \"method\": \"Mouse glomerulonephritis model, flow cytometry, scRNA-seq, in vitro monocyte-endothelial cell co-culture, CCR2-/- and TNFR2-/- mice\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO plus in vitro mechanistic reconstitution plus scRNA-seq, single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"35404389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CCR2 signaling in breast cancer cells (not only in monocytes) suppresses adaptive anti-tumor immunity by reducing MHC-I expression, upregulating PD-L1, and preventing CD103+ cross-presenting DC maturation; Ccr2 deletion in cancer cells increased CTL and CD103+ DC infiltration and activation.\",\n      \"method\": \"Ccr2 genetic deletion in cancer cells, orthotopic isograft mouse model, flow cytometry, pharmacological CCR2 targeting, Batf3-/- epistasis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO in cancer cells plus epistasis with Batf3-/- mice, single lab\",\n      \"pmids\": [\"32667673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CCR2 signaling promotes infiltration of classical monocytes into the lung parenchyma during SARS-CoV-2 infection; CCR2-deficient mice exhibit higher viral loads, increased viral dissemination, and elevated inflammatory cytokines, indicating CCR2-dependent monocyte recruitment is protective against viral replication.\",\n      \"method\": \"CCR2-/- mice, mouse-adapted SARS-CoV-2 model, intravital antibody labeling, scRNA-seq, flow cytometry\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CCR2-/- genetic model with multiple mechanistic readouts, single lab\",\n      \"pmids\": [\"34749524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Tissue-resident CCR2+ cardiac macrophages promote monocyte recruitment after myocardial injury through an MYD88-dependent mechanism that results in release of monocyte chemoattractant proteins; CCR2- cardiac macrophages inhibit monocyte recruitment. Selective depletion of either subset before MI yields divergent effects on ventricular function and remodeling.\",\n      \"method\": \"Syngeneic cardiac transplantation, intravital 2-photon microscopy, CCR2-DTR and CD169-DTR depletion models, scRNA-seq, MYD88-knockout macrophages\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — intravital imaging plus genetic depletion models plus scRNA-seq with clear mechanistic epistasis\",\n      \"pmids\": [\"30582448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Heart-resident CCR2+ macrophages drive neutrophil extravasation into ischemic myocardium through a TLR9/MyD88/CXCL5 signaling pathway; CXCL2 and CXCL5 play critical and non-redundant roles in guiding neutrophil adhesion and crawling, respectively.\",\n      \"method\": \"Cardiac transplant ischemia-reperfusion model, intravital 2-photon imaging, TLR9/MyD88/CXCL5 pathway dissection, neutralizing antibodies\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — intravital imaging with genetic/antibody pathway dissection, replicated across multiple approaches\",\n      \"pmids\": [\"27536731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CCL2-CCR2 signaling on cancer cells facilitates perineural invasion; cancer cell CCR2 expression correlates with MAPK and Akt pathway activity and migration toward CCL2/dorsal root ganglia; use of CCL2-/- DRG significantly reduces cancer cell perineural invasion compared to CCL2+/+ DRG.\",\n      \"method\": \"In vitro nerve-cancer co-culture perineural invasion assays, CCL2-/- knockout DRG, CCR2 expression correlation with signaling pathway activity, immunohistochemistry on patient specimens\",\n      \"journal\": \"Molecular cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — CCL2 KO mechanistic model plus in vitro functional assays, single lab\",\n      \"pmids\": [\"25312961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CCR2 on hematopoietic cells is required for macrophage infiltration and osteoclast recruitment in fracture healing; CCR2-/- osteoclasts exhibit decreased bone resorption capacity independent of osteoclast number, indicating a direct role of CCR2 in osteoclast function.\",\n      \"method\": \"CCR2-/- mice, fracture healing model, histology, bone resorption assays, macrophage quantification\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with in vitro and in vivo functional assays, single lab\",\n      \"pmids\": [\"20354109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CCR2+ macrophages constitute the majority of fibrin-uptaking cells in extravascular space; fibrin endocytosis is plasminogen/plasminogen activator-dependent but independent of αMβ2, ICAM-1, or the mannose receptor, defining a distinct intracellular pathway for extravascular fibrin clearance.\",\n      \"method\": \"Intravital microscopy, CCR2-expressing cell elimination, plasminogen-/- and receptor KO mice, lysosomal targeting assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — intravital imaging plus multiple KO epistasis experiments, single lab\",\n      \"pmids\": [\"26647393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CCR2/CCL2 signaling in decidual macrophages operates through JAK2/STAT3 downstream of CCR2; pharmacological CCR2 or JAK2 inhibition reduces decidual macrophage proportion and M1/M2 marker expression, and impairs placental labyrinth development and pregnancy outcomes.\",\n      \"method\": \"CCR2 and JAK2 inhibitors in vivo, monocyte-DSC co-culture, flow cytometry, embryo resorption assay\",\n      \"journal\": \"American journal of reproductive immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — pharmacological pathway dissection in vivo and in vitro, single lab\",\n      \"pmids\": [\"34191381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CCR2 deficiency in mice results in ~80-90% reduction in brain macrophage numbers after traumatic brain injury, leading to improved spatial learning, memory, and neuronal survival in hippocampal CA1-CA3 regions, establishing CCR2 as the primary driver of macrophage recruitment to the traumatically injured brain.\",\n      \"method\": \"CCR2-/- mice, controlled cortical impact TBI model, flow cytometry, behavioral testing (open field, rotarod, Morris water maze), histology\",\n      \"journal\": \"Journal of neurotrauma\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple functional readouts, single lab\",\n      \"pmids\": [\"24806994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CCR2-deficient mice show reduced lymphatic vessel density; conversely, ACKR2-deficient mice show increased lymphatic vessel density; CCL2 (scavenged by ACKR2, signaling through CCR2) regulates pro-lymphangiogenic macrophage proximity to developing lymphatic vessels.\",\n      \"method\": \"CCR2-/- and ACKR2-/- mice, tissue lymphatic vessel density quantification, macrophage localization studies, regeneration models\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal genetic KO phenotypes with mechanistic macrophage localization data\",\n      \"pmids\": [\"25271254\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CCR2 is a Gαi-coupled seven-transmembrane chemokine receptor that binds CCL2 (and additional ligands including CCL7, CCL8, PSMP, CYTL1, and eotaxin as antagonist) at its extracellular transmembrane domain and at a distinct intracellular allosteric site; upon agonist binding it drives monocyte/macrophage chemotaxis via Gαi–ERK/Akt–PI3K pathways, undergoes dynamin- and clathrin-dependent internalization regulated by filamin A phosphorylation for recycling, can also constitutively internalize as a chemokine scavenger independently of G proteins/GRKs/β-arrestins/clathrin, forms hetero-oligomers with CCR5 and CXCR4 enabling allosteric cross-inhibition, and in cardiac macrophages activates a MYD88/TLR9-dependent program for monocyte recruitment and neutrophil extravasation, while in the vasculature initiating CCR2–TNFR2-dependent monocyte-to-macrophage differentiation.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"CCR2 was molecularly cloned as the MCP-1 (CCL2) receptor; expression in Xenopus oocytes demonstrated that CCR2 confers robust intracellular calcium mobilization in response to nanomolar MCP-1 but not related chemokines, establishing it as a G protein-coupled, seven-transmembrane receptor with two isoforms (CCR2A and CCR2B) arising from alternative splicing of the C-terminal tail.\",\n      \"method\": \"cDNA cloning, heterologous expression in Xenopus oocytes, calcium flux assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — functional reconstitution in heterologous system with rigorous ligand specificity controls; foundational cloning paper\",\n      \"pmids\": [\"8146186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CCR2 mRNA stability is regulated by LPS through a two-step process: LPS first triggers deadenylation of CCR2 mRNA, followed by degradation of the message body, rapidly reducing steady-state CCR2 mRNA levels in monocytes.\",\n      \"method\": \"mRNA stability assay (actinomycin D chase), poly(A) tail analysis, Northern blot\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical dissection of mRNA decay mechanism in primary cells, single lab\",\n      \"pmids\": [\"9365120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The CCR2-64I polymorphism (Val64Ile in TM1) is efficiently expressed on the cell surface but does not exert dominant-negative activity on CCR5 coreceptor function, and does not alter CCR5 mRNA or surface expression levels in primary CD4+ T cells, indicating its AIDS-delaying effect is not mediated through CCR5 regulation.\",\n      \"method\": \"Flow cytometry, RT-PCR, HIV-1 coreceptor function assay, transfected cell reporter constructs\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods with primary cells and transfected constructs; single lab study\",\n      \"pmids\": [\"9971830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Endothelial cells express functional CCR2 (mRNA and surface protein), and MCP-1 stimulation promotes endothelial cell migration in a transwell assay that is blocked by a CCR2 antagonist (9-76 MCP-1) or anti-MCP-1 antibody, implicating CCR2 in endothelial wound repair.\",\n      \"method\": \"RT-PCR, RNase protection, Western blot, flow cytometry, transwell migration assay with receptor antagonist, immunohistochemistry\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods with functional receptor antagonist validation; single lab\",\n      \"pmids\": [\"10479649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CCR2 expressed on pleural mesothelial cells mediates MCP-1-dependent haptotactic migration; blocking CCR2 with neutralizing antibodies abolished haptotaxis, and IL-2 upregulated CCR2 expression correlating with enhanced haptotactic capacity, while LPS initially downregulated it.\",\n      \"method\": \"FACS analysis of CCR2 expression, neutralizing antibody blockade, haptotaxis assay, RT-PCR\",\n      \"journal\": \"American journal of physiology. Lung cellular and molecular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor blockade with functional readout, multiple methods; single lab\",\n      \"pmids\": [\"10710532\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Eotaxin acts as a natural CCR2 antagonist: it displaces 125I-MCP-1 from monocytes in a concentration-dependent manner and inhibits MCP-1-induced chemotaxis and enzyme release without triggering CCR2 internalization, whereas it functions as a CCR5 agonist (100 nM) and induces CCR5 internalization.\",\n      \"method\": \"Radioligand binding assay, chemotaxis assay, receptor internalization assay, enzyme release assay using primary human monocytes and CCR2/CCR5-transfected cells\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — radioligand binding with functional assays in both primary monocytes and reconstituted transfected cells; multiple orthogonal readouts\",\n      \"pmids\": [\"11264152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CCR2 and CCR5 undergo ligand-induced heterodimerization; MCP-1 and RANTES cooperate synergistically (10–100-fold lower threshold) when both receptors are co-expressed, recruiting both receptor-associated signaling complexes and additionally engaging Gq/11, resulting in pertussis toxin-resistant Ca2+ flux and cell adhesion rather than chemotaxis.\",\n      \"method\": \"Co-immunoprecipitation, BRET, Ca2+ flux assay, pertussis toxin treatment, chemotaxis assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct protein interaction demonstrated by co-IP plus distinct functional readouts distinguishing homo- vs. heterodimer signaling outcomes\",\n      \"pmids\": [\"11350939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Matrix metalloproteinase cleavage of MCP-1 (CCL2) between residues 4 and 5 generates N-terminally truncated forms that bind CCR2 but lack chemoattractant activity and instead act as potent CCR2 antagonists, reducing inflammatory edema >66% in vivo.\",\n      \"method\": \"Recombinant MMP cleavage assays, radioligand competition binding on CCR2-transfected cells, transwell migration assay, carrageenan paw edema model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic cleavage with defined products, receptor binding, functional antagonism, and in vivo validation\",\n      \"pmids\": [\"12149192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Site-directed mutagenesis guided by a rhodopsin-homology model of CCR2 identified specific transmembrane residues required for binding of indole-piperidine class antagonists; docking studies and SDM results together defined the orthosteric antagonist binding pocket within the transmembrane bundle.\",\n      \"method\": \"Homology modeling (bovine rhodopsin template), site-directed mutagenesis, radioligand binding assay\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — structure-function mutagenesis with functional binding readout; single lab\",\n      \"pmids\": [\"12954060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"MCP-1 signals through an alternative receptor in CCR2-/- arterial smooth muscle cells at physiologic concentrations; this alternative receptor signals via pertussis toxin-sensitive Gαi, mobilizes intracellular Ca2+, activates p42/44 MAPK, and induces tissue-factor activity—a pathway inhibited by PD98059 (MEK inhibitor) but not SB203580 (p38 inhibitor).\",\n      \"method\": \"CCR2-/- mouse SMC preparation, pertussis toxin treatment, intracellular Ca2+ measurement, phospho-MAPK immunoblot, tissue-factor activity assay, selective kinase inhibitors\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function genetics combined with pharmacological dissection; single lab, multiple readouts\",\n      \"pmids\": [\"15020650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CCR2 is essential for monocyte mobilization from bone marrow into blood and for subsequent recruitment from blood to inflamed tissue; CCR2-/- mice accumulate monocytes in bone marrow with decreased circulating numbers, and adoptive transfer of CCR2-/- monocytes into wild-type hosts demonstrates a cell-autonomous requirement for CCR2 in efficient tissue recruitment. MCP-3 and MCP-1 are the critical CCR2 agonists maintaining normal blood monocyte counts.\",\n      \"method\": \"CCR2-/- and MCP knockout mouse analysis, ex vivo labeling and adoptive transfer, flow cytometry, MCP ligand knockout comparison\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function plus adoptive transfer establishes cell-autonomous CCR2 requirement; replicated across multiple knockout lines\",\n      \"pmids\": [\"17364026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CCR2 undergoes transportin-1 (TRN1)-dependent nuclear translocation after agonist stimulation; TRN1 directly binds CCR2 (interaction increasing over time with agonist treatment) and promotes receptor internalization and nuclear envelope localization.\",\n      \"method\": \"Modified CCR2 bait construct, co-immunoprecipitation, confocal microscopy, TRN1 knockdown\",\n      \"journal\": \"Proteomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — novel subcellular localization finding; single Co-IP plus imaging, single lab\",\n      \"pmids\": [\"18846510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CCR2, CCR5, and CXCR4 form hetero-oligomeric complexes of at least three receptors; demonstrated by bimolecular luminescence complementation and BRET. Negative binding cooperativity between binding pockets was shown in T cells and monocytes, and selective CCR2/CCR5 antagonist TAK-779 cross-inhibits CXCR4-promoted cell recruitment in vivo via these oligomeric complexes.\",\n      \"method\": \"Bimolecular luminescence complementation, BRET, radioligand binding cooperativity assay in primary leukocytes, air-pouch model in vivo\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — two orthogonal FRET/complementation methods plus functional validation in primary cells and in vivo; single lab with multiple methods\",\n      \"pmids\": [\"19758998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"FROUNT binds to the C-terminal region of CCR2 and enhances CCR2-mediated directional chemotaxis by amplifying sensing of shallow chemokine gradients, consolidating pseudopodium formation toward the source; FROUNT suppression results in multiple unfocused pseudopodia and impaired directional response.\",\n      \"method\": \"Co-immunoprecipitation, overexpression/knockdown, live-cell chemotaxis assay with pseudopod quantification\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-IP plus functional phenotype; single lab\",\n      \"pmids\": [\"19841162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"After CCL2 binding, CCR2 internalizes via a combination of clathrin-dependent and clathrin-independent pathways, reaching early endosomes and then lysosomes; dynamin inhibition (dynasore) blocks both CCR2 internalization and ERK1/2 activation, linking dynamin-sensitive endocytosis to downstream signaling.\",\n      \"method\": \"RNAi knockdown of clathrin, dynasore treatment, confocal microscopy, immunoblot (phospho-ERK1/2)\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological perturbation with multiple readouts; single lab\",\n      \"pmids\": [\"19643177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Beta-defensins 2 and 3 (human) and their mouse orthologs (mBD4 and mBD14) bind CCR2-transfected HEK293 cells and induce CCR2-specific chemotaxis of human monocytes and mouse peritoneal exudate cells; this chemotaxis is abolished by pre-incubation with CCL2/MCP-1 and is absent in CCR2-/- cells, establishing these defensins as functional CCR2 ligands.\",\n      \"method\": \"Flow cytometry binding assay (Fc-fusion proteins on CCR2-transfected HEK293), chemotaxis assay with CCR2-/- cells, competitive inhibition with CCL2\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding assay plus functional validation with genetic knockout controls; multiple orthogonal approaches\",\n      \"pmids\": [\"20483750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SphK1 in hepatic stellate cells upregulates CCR2 expression by downregulating miR-19b-3p (which directly targets CCR2 mRNA), while SphK1 in Kupffer cells promotes CCL2 secretion; this SphK1→miR-19b-3p↓→CCR2↑ axis in HSCs drives their activation and migration in liver fibrosis.\",\n      \"method\": \"SphK1 knockout mice, bone marrow transplantation, miRNA overexpression/inhibition, qRT-PCR, Western blot, in vitro HSC migration assay\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO plus miRNA mechanistic dissection and BMT validation; single lab\",\n      \"pmids\": [\"29572892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A group of allosteric CCR2 antagonists (CCR2-RA-[R], JNJ-27141491, SD-24) bind an intracellular site distinct from the orthosteric chemokine-binding pocket; mutagenesis identified Y7.53 and F8.50 of the NPxxYx5,6F motif, V6.36, and K8.49 in helix VIII as critical residues, demonstrating for the first time an intracellular allosteric binding site on CCR2.\",\n      \"method\": \"Chimeric CCR2/CCR5 receptor approach, site-directed mutagenesis, radioligand binding assay, IP1 functional assay\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — chimeric receptor mapping plus systematic mutagenesis with functional validation; multiple constructs and readouts\",\n      \"pmids\": [\"25024169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CCL2 in the CCR2/CCR5 signaling context: CCR2-CCR2 homodimerization is required for Ca2+ flux and chemotaxis, and CCR2/CCR5 heterodimerization recruits Gq/11 and additional signaling pathways leading to cell adhesion; the CCL2-CCR2 axis in human mesangial cells signals through CCR2 to upregulate ICAM-1 expression and enhance monocyte adhesion, blocked by the CCR2 antagonist RS102895.\",\n      \"method\": \"CCR2 blockade with RS102895, immunofluorescence, cytofluorimetry, RT-PCR, immunoblotting, monocyte adhesion assay\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological CCR2 blockade with multiple cellular readouts; single lab\",\n      \"pmids\": [\"16518346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Filamin A (FLNa) regulates CCR2B endosomal recycling: FLNa knockdown causes activated CCR2B to accumulate in enlarged EEA-1+ endosomes with impaired exit; FLNa and CCR2B co-localize in actin-enriched endosomal microdomains, and CCR2B signaling induces phosphorylation of FLNa at S2152, which sustains receptor recycling back to the plasma membrane.\",\n      \"method\": \"FLNa siRNA knockdown, super-resolution microscopy, FRAP, EEA-1 co-localization, phospho-FLNa immunoblot, CCR2B trafficking assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — super-resolution imaging plus genetic knockdown and phospho-site identification; single lab with multiple methods\",\n      \"pmids\": [\"27909248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CYTL1 is identified as a functional CCR2B ligand: it induces CCR2B internalization, ERK pathway-dependent chemotaxis of human monocytes, and macrophage chemotaxis from wild-type but not Ccr2-/- mice; chemotactic activity is sensitive to pertussis toxin, indicating Gi-coupled signaling through CCR2B.\",\n      \"method\": \"Chemotaxis assay, receptor internalization assay, radioligand competitive binding, pertussis toxin treatment, Ccr2-/- macrophage assay, CCR2B-transfected HEK293 cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — binding, internalization, and functional chemotaxis assays in reconstituted cells and primary cells including genetic knockout validation\",\n      \"pmids\": [\"27084102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PCSK9, secreted from LPS-stimulated vascular smooth muscle cells via a TLR4-SAPK/JNK pathway, reduces LDL-R on monocytes; this LDL-R reduction limits LDL-C-dependent upregulation of CCR2, thereby inhibiting CCR2-mediated monocyte chemotaxis toward MCP-1.\",\n      \"method\": \"VSMC conditioned media experiments, TLR4 blockade, JNK inhibitor SP600125, monocyte LDL-R and CCR2 flow cytometry, chemotaxis assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection with functional migration readout; single lab\",\n      \"pmids\": [\"28232185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NOX4 in hepatic stellate cells stabilizes CCR2 and CCL2 mRNA by phosphorylating HuR at Ser221, causing its cytoplasmic shuttling; HSC-specific NOX4 knockout reduces CCR2 and CCL2 expression and inflammatory cell recruitment in alcoholic liver injury.\",\n      \"method\": \"HSC-specific NOX4 knockout mice, mRNA half-life assay, HuR phospho-immunoblot, cytoplasmic fractionation, qRT-PCR\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-specific genetic KO plus mechanistic HuR phosphorylation/localization data; single lab\",\n      \"pmids\": [\"28383062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Tissue-resident CCR2+ cardiac macrophages promote monocyte recruitment through a MyD88-dependent mechanism resulting in release of monocyte chemoattractant proteins and monocyte mobilization; tissue-resident CCR2- cardiac macrophages inhibit monocyte recruitment. Selective depletion of either subset has divergent effects on cardiac function and remodeling after MI.\",\n      \"method\": \"Syngeneic cardiac transplantation, intravital 2-photon microscopy, CCR2-DTR and CD169-DTR depletion models, single-cell RNA sequencing, MyD88 genetic analysis\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo intravital imaging, selective depletion genetics, and scRNA-seq; multiple orthogonal approaches\",\n      \"pmids\": [\"30582448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Molecular dynamics simulations coupled with Markov-state modeling show that an orthosteric and an allosteric CCR2 antagonist each shift CCR2 into distinct stable inactive conformations, disrupting a continuous internal water and sodium ion pathway that is required for transitions to the active state; apo simulations reveal intermediate conformations along the activation pathway.\",\n      \"method\": \"Long-timescale molecular dynamics, Markov-state model analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational only, no experimental validation in this study\",\n      \"pmids\": [\"30975755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PSMP (PC3-secreted microprotein) binds CCR2 and promotes liver fibrosis through CCR2-dependent inflammatory macrophage infiltration and hepatic stellate cell activation; AAV8-mediated PSMP overexpression in Psmp-/- livers rescues fibrosis only in a CCR2-dependent manner, and a PSMP-neutralizing antibody prevents injury.\",\n      \"method\": \"Psmp-/- mice, AAV8 overexpression rescue, CCR2-dependence test (CCR2 pathway), in vitro macrophage polarization and LX-2 activation assay, anti-PSMP antibody treatment\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout plus rescue experiment plus antibody blockade; multiple in vivo and in vitro approaches\",\n      \"pmids\": [\"31813573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CCR2 signaling in monocytes is required for their differentiation into macrophages within the vasculature during glomerulonephritis; mechanistically, CCR2 in circulating cells cooperates with TNFR2 in parenchymal cells—TNF-TNFR2-activated endothelial cells generate CCR2 ligands that drive CCR2-dependent monocyte differentiation, establishing a feed-forward autocrine loop. scRNA-seq defined a CCR2-dependent monocyte differentiation path associated with immune effector function acquisition.\",\n      \"method\": \"Flow cytometry of nephritic kidneys, CCR2-deficient monocyte analysis, in vitro monocyte-endothelial cell coculture, scRNA-seq, human lupus nephritis urine analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function, reconstitution in vitro, scRNA-seq mechanistic pathway definition; multiple orthogonal methods\",\n      \"pmids\": [\"35404389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CCR2 signaling promotes classical monocyte infiltration into the lung and expansion of monocyte-derived cells during SARS-CoV-2 infection; CCR2-/- mice show higher viral loads, increased lung viral dissemination, and elevated inflammatory cytokines, demonstrating that the CCR2-monocyte axis restricts viral burden.\",\n      \"method\": \"Mouse-adapted SARS-CoV-2 infection model, CCR2-/- mice, intravital antibody labeling, scRNA-seq, flow cytometry\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with defined viral and immunological phenotypes, scRNA-seq; single lab\",\n      \"pmids\": [\"34749524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CCR2 signaling in cancer (breast) cells suppresses the adaptive immune response: Ccr2 deletion in cancer cells increased infiltration and activation of cytotoxic T lymphocytes and CD103+ cross-presenting DCs, upregulated MHC-I, and downregulated PD-L1; effects were CD103+ DC-dependent as shown in Batf3-/- mice.\",\n      \"method\": \"Orthotopic isograft mouse model, CRISPR Ccr2 deletion, flow cytometry, pharmacological CCR2 inhibition, Batf3-/- epistasis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic deletion + pharmacological + epistasis in vivo; multiple orthogonal approaches, rigorous controls\",\n      \"pmids\": [\"32667673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cryo-EM structure of the CCL2-CCR2-Gα-protein complex reveals that CCL2 inserts deeply into the extracellular half of the CCR2 transmembrane domain with the most N-terminal glutamine forming critical interactions; intracellular loop 2 interactions are more critical for G-protein activation than intracellular loop 3 interactions, and extensive hydrophobic/polar interactions with Gα contribute to constitutive receptor activity.\",\n      \"method\": \"Cryo-electron microscopy structure determination, functional experiments (mutagenesis of ICL2/ICL3 residues validated by signaling assay)\",\n      \"journal\": \"Cell discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure with functional mutagenesis validation; high-resolution mechanistic insight\",\n      \"pmids\": [\"35570218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CCR2 acts as a dual-function receptor: it drives monocyte chemotaxis (G protein-dependent) AND scavenges CCL2 by constitutive internalization and recycling to the cell surface. The scavenging function is mechanistically distinct from classical GPCR desensitization—it occurs independently of G proteins, GRKs, β-arrestins, and clathrin, unlike professional scavenger receptors.\",\n      \"method\": \"CRISPR knockout cell lines (G protein, GRK, β-arrestin, clathrin), CCL2 scavenging assay, receptor recycling assay\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic CRISPR-KO of all candidate pathway components with quantitative scavenging and recycling readouts; rigorous mechanistic dissection\",\n      \"pmids\": [\"36719944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Human autosomal recessive complete CCR2 deficiency causes pulmonary alveolar proteinosis and polycystic lung disease; loss-of-function CCR2 variants abolish CCL2-stimulated Ca2+ signaling and monocyte migration, resulting in approximately half the normal alveolar macrophage count due to impaired CCL2-dependent monocyte migration to the lung.\",\n      \"method\": \"Human genetics (homozygous and compound heterozygous patients), Ca2+ flux assay, monocyte migration assay, alveolar macrophage quantification\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — human loss-of-function genetics validated by functional Ca2+ signaling and migration assays; five independent kindreds\",\n      \"pmids\": [\"38157855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Peripheral CCL2-CCR2 signaling in macrophages and T cells (but not TG neurons) is required for chronic headache sensitization; CCR2 deletion in myeloid cells or T cells individually abolished NTG-induced facial hypersensitivity, and CCR2 signaling was mechanistically linked to enhanced CGRP and PACAP production in TG neurons.\",\n      \"method\": \"Global and cell-type-specific Ccr2 knockout mice, conditional deletion, CCL2 neutralizing antibody, behavioral testing, CGRP/PACAP measurement\",\n      \"journal\": \"Brain: a journal of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific genetic deletion with rigorous behavioral and molecular phenotypes; multiple conditional knockouts\",\n      \"pmids\": [\"37284790\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CCR2 is a Gαi-coupled seven-transmembrane chemokine receptor that binds CCL2 (MCP-1) and related ligands (CCL7, CCL8, CYTL1, beta-defensins, PSMP) with high affinity—as revealed by its cryo-EM structure showing deep CCL2 insertion into the transmembrane domain and ICL2-dominant G-protein coupling—mediating monocyte/macrophage mobilization from bone marrow and recruitment to inflamed tissues; it also functions as a constitutive CCL2 scavenger receptor through a G protein/GRK/β-arrestin/clathrin-independent internalization-recycling cycle, forms hetero-oligomers with CCR5 and CXCR4 that produce cross-inhibitory signaling, engages an intracellular allosteric binding site targetable by small-molecule antagonists, and regulates downstream signaling through dynamin-dependent ERK1/2 activation and filamin A phosphorylation-dependent endosomal recycling, with its mRNA stability controlled by LPS-induced deadenylation/degradation and by NOX4-mediated HuR phosphorylation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CCR2 is a Gαi-coupled seven-transmembrane chemokine receptor that serves as the principal mediator of monocyte/macrophage chemotaxis and tissue recruitment in inflammation, infection, injury, and development. Cryo-EM structures show that CCL2 inserts deeply into the extracellular transmembrane domain to activate the receptor, while a distinct intracellular allosteric antagonist site is defined by residues in the NPxxYx(5,6)F motif and helix VIII; additional ligands including CYTL1 and PSMP signal through CCR2 via pertussis toxin–sensitive Gαi–ERK/Akt pathways, and eotaxin acts as a natural antagonist [PMID:35570218, PMID:25024169, PMID:27084102, PMID:11264152]. Beyond classical chemotaxis, CCR2 constitutively internalizes and scavenges CCL2 independently of G proteins, GRKs, β-arrestins, and clathrin, forms hetero-oligomeric complexes with CCR5 and CXCR4 enabling allosteric cross-inhibition, and in tissue-resident cardiac macrophages activates a MYD88/TLR9-dependent program for neutrophil extravasation [PMID:36719944, PMID:19758998, PMID:27536731]. Human complete loss-of-function CCR2 deficiency abolishes monocyte migration, reduces alveolar macrophages, and causes pulmonary alveolar proteinosis and polycystic lung disease [PMID:38157855].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Discovery that CCR2 mRNA is post-transcriptionally regulated by LPS-triggered deadenylation-first decay established that receptor availability is controlled at the mRNA stability level, not solely by transcription.\",\n      \"evidence\": \"mRNA stability and poly(A) tracking assays in LPS-stimulated monocytes\",\n      \"pmids\": [\"9365120\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"decay machinery (deadenylases) responsible was not identified\", \"no link to in vivo receptor surface dynamics\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of eotaxin as a natural antagonist of CCR2 demonstrated that endogenous chemokines can cross-regulate receptor function without triggering internalization, establishing a ligand-level control mechanism for monocyte chemotaxis.\",\n      \"evidence\": \"Radioligand displacement, chemotaxis, and internalization assays on monocytes and transfected cells\",\n      \"pmids\": [\"11264152\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"structural basis of eotaxin antagonism at CCR2 not resolved\", \"in vivo relevance of cross-antagonism not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Homology modeling and mutagenesis first mapped the small-molecule antagonist binding pocket within the CCR2 transmembrane domain, providing the initial structural framework for receptor pharmacology.\",\n      \"evidence\": \"Site-directed mutagenesis guided by rhodopsin-based homology model with ligand docking\",\n      \"pmids\": [\"12954060\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"based on rhodopsin template, not actual CCR2 structure\", \"only tested indole piperidine series\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Three discoveries collectively revealed that CCR2 functions within a higher-order signaling network: it forms hetero-oligomers with CCR5/CXCR4 enabling allosteric cross-inhibition, internalizes via clathrin-dependent and -independent pathways requiring dynamin for both trafficking and ERK signaling, and its chemotactic output is amplified by the cytoplasmic adapter FROUNT.\",\n      \"evidence\": \"BRET/BiLC for oligomerization plus in vivo validation; RNAi/dynasore for trafficking; co-IP and knockdown for FROUNT\",\n      \"pmids\": [\"19758998\", \"19643177\", \"19841162\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"stoichiometry and dynamics of hetero-oligomers in native membranes unknown\", \"FROUNT binding site on CCR2 C-terminus not structurally defined\", \"relative contribution of clathrin-dependent vs. -independent routes in vivo unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of a distinct intracellular allosteric binding site — mapped to conserved NPxxYx(5,6)F motif residues, V6.36, and K8.49 — established that CCR2 can be pharmacologically modulated from two topographically separate sites, fundamentally changing drug design strategies.\",\n      \"evidence\": \"Chimeric CCR2/CCR5 receptors, single-point mutagenesis, radioligand binding, and IP turnover assays\",\n      \"pmids\": [\"25024169\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"no co-crystal or cryo-EM structure of intracellular antagonist bound\", \"cooperativity between orthosteric and allosteric sites not quantified in native cells\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Multiple studies established that CCR2 marks a functionally distinct subset of tissue-resident cardiac macrophages that orchestrate innate immune cell recruitment: these CCR2+ macrophages drive neutrophil extravasation via TLR9/MyD88/CXCL5 and promote monocyte chemoattractant production, while filamin A phosphorylation controls CCR2 endosomal recycling to sustain receptor surface expression.\",\n      \"evidence\": \"Cardiac transplant models with intravital 2-photon imaging and pathway dissection; super-resolution microscopy and FRAP for FLNa-CCR2 trafficking\",\n      \"pmids\": [\"27536731\", \"27909248\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"how TLR9 ligands are generated in ischemic tissue not fully defined\", \"FLNa-CCR2 interaction not validated in primary cardiac macrophages\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Discovery that CYTL1 signals through CCR2B via Gαi–ERK expanded the receptor's ligand repertoire beyond CC chemokines, showing CCR2 integrates diverse soluble cues for monocyte chemotaxis.\",\n      \"evidence\": \"Chemotaxis, receptor internalization, radioligand binding in WT and Ccr2−/− macrophages with pertussis toxin blockade\",\n      \"pmids\": [\"27084102\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"CYTL1 binding site on CCR2 not structurally resolved\", \"physiological contexts requiring CYTL1-CCR2 axis not defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Tissue-resident CCR2+ cardiac macrophages were shown to require MYD88 for their monocyte-recruiting function after myocardial injury, with selective depletion of CCR2+ vs CCR2− subsets yielding opposite effects on ventricular remodeling, establishing functional heterogeneity among cardiac macrophage populations.\",\n      \"evidence\": \"CCR2-DTR and CD169-DTR depletion models, intravital 2-photon microscopy, scRNA-seq, MYD88-KO macrophages\",\n      \"pmids\": [\"30582448\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"upstream signals activating MYD88 in CCR2+ resident macrophages incompletely defined\", \"whether human cardiac macrophage subsets mirror murine CCR2+/CCR2− dichotomy not established\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"The cryo-EM structure of the CCL2–CCR2–Gi complex provided the first atomic-resolution view of agonist engagement, showing deep insertion of CCL2 into the transmembrane bundle and revealing that intracellular loop 2 contacts are more critical for G-protein coupling than loop 3, resolving longstanding questions about activation mechanism.\",\n      \"evidence\": \"Cryo-EM at near-atomic resolution with structure-guided mutagenesis and functional validation\",\n      \"pmids\": [\"35570218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"structure of CCR2 bound to non-chemokine ligands (CYTL1, PSMP) unavailable\", \"no structure of intracellular allosteric antagonist-bound state\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"CRISPR-based dissection revealed that CCR2 operates as a dual-function receptor: it drives G-protein-mediated chemotaxis and independently scavenges CCL2 via constitutive internalization that is independent of G proteins, GRKs, β-arrestins, and clathrin, redefining CCR2 as a non-classical scavenger receptor.\",\n      \"evidence\": \"Systematic CRISPR knockout of signaling and trafficking components with CCL2 scavenging and internalization assays\",\n      \"pmids\": [\"36719944\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"molecular machinery mediating clathrin/arrestin-independent constitutive internalization unknown\", \"relative contribution of scavenging vs. signaling in tissue homeostasis not quantified\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Human loss-of-function genetics proved that CCR2 is essential for monocyte migration to the lungs and alveolar macrophage homeostasis, with complete CCR2 deficiency causing pulmonary alveolar proteinosis and polycystic lung disease.\",\n      \"evidence\": \"Human patients with biallelic loss-of-function CCR2 variants; Ca2+ signaling, migration assays, BAL macrophage counts, serum CCL2\",\n      \"pmids\": [\"38157855\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether other tissue macrophage populations are similarly dependent on CCR2 in humans not characterized\", \"mechanism linking CCR2 loss to cyst formation not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the molecular machinery for CCR2's constitutive scavenging pathway, structural basis of non-chemokine ligand recognition (CYTL1, PSMP), the functional significance of CCR2 hetero-oligomerization stoichiometry in vivo, and whether the intracellular allosteric site can be exploited for biased pharmacology that separates chemotaxis from scavenging.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"no structure of CYTL1- or PSMP-bound CCR2\", \"constitutive internalization machinery unidentified\", \"biased agonism at allosteric site not tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 4, 12, 22]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 7, 8, 22]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [6, 7]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [6, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [12, 22, 25, 26, 27]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 3, 12, 28]}\n    ],\n    \"complexes\": [\n      \"CCR2-CCR5-CXCR4 hetero-oligomer\"\n    ],\n    \"partners\": [\n      \"CCL2\",\n      \"CCR5\",\n      \"CXCR4\",\n      \"FLNA\",\n      \"FROUNT\",\n      \"CYTL1\",\n      \"PSMP\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"CCR2 is a Gαi-coupled seven-transmembrane chemokine receptor that serves as the principal mediator of monocyte/macrophage mobilization from bone marrow and recruitment to inflamed tissues in response to CCL2 (MCP-1) and additional ligands including CCL7, CYTL1, beta-defensins, and PSMP [PMID:8146186, PMID:17364026, PMID:27084102, PMID:20483750, PMID:31813573]. Beyond classical chemotaxis, CCR2 functions as a constitutive CCL2 scavenger receptor through a G protein-, GRK-, β-arrestin-, and clathrin-independent internalization–recycling cycle, and forms hetero-oligomeric complexes with CCR5 and CXCR4 that produce cross-inhibitory binding cooperativity and qualitatively distinct signaling outputs including Gq/11-coupled cell adhesion [PMID:36719944, PMID:11350939, PMID:19758998]. The cryo-EM structure of the CCL2–CCR2–Gα complex reveals deep CCL2 insertion into the transmembrane domain and a dominant role for intracellular loop 2 in G-protein coupling, while mutagenesis has defined a pharmacologically targetable intracellular allosteric site within the NPxxYx₅₆F motif [PMID:35570218, PMID:25024169]. Autosomal recessive loss-of-function CCR2 mutations in humans cause pulmonary alveolar proteinosis and polycystic lung disease due to impaired monocyte migration and reduced alveolar macrophage numbers [PMID:38157855].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Molecular cloning of CCR2 as the MCP-1 receptor resolved the identity of the GPCR mediating monocyte chemotaxis to CCL2 and revealed two C-terminal splice isoforms (CCR2A/B).\",\n      \"evidence\": \"cDNA cloning with heterologous expression in Xenopus oocytes demonstrating ligand-selective calcium flux\",\n      \"pmids\": [\"8146186\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative signaling properties of CCR2A vs CCR2B isoforms not resolved\", \"Endogenous ligand repertoire beyond MCP-1 unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Discovery that CCR2 and CCR5 heterodimerize and that eotaxin functions as a natural CCR2 antagonist established that CCR2 signaling is modulated by receptor oligomerization and non-cognate ligands, producing qualitatively distinct outputs (Gq/11-coupled adhesion vs. Gi-coupled chemotaxis).\",\n      \"evidence\": \"Co-immunoprecipitation, BRET, pertussis toxin-resistant Ca²⁺ flux for heterodimers; radioligand displacement and chemotaxis blockade for eotaxin antagonism\",\n      \"pmids\": [\"11350939\", \"11264152\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of heterodimeric complexes undefined\", \"Structural basis of Gq/11 coupling by heterodimers not determined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Genetic loss-of-function studies in mice established that CCR2 is cell-autonomously required for monocyte egress from bone marrow and tissue recruitment, identifying MCP-1 and MCP-3 as the critical in vivo agonists maintaining circulating monocyte counts.\",\n      \"evidence\": \"CCR2−/− mice with adoptive transfer of labeled monocytes into wild-type hosts; MCP ligand knockout comparisons\",\n      \"pmids\": [\"17364026\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of individual CCR2 ligands in specific tissues not fully parsed\", \"Mechanism of CCR2-dependent bone marrow release not molecularly defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification of CCR2/CCR5/CXCR4 hetero-oligomeric complexes with negative binding cooperativity explained how selective CCR2 antagonists can cross-inhibit CXCR4 function, expanding the pharmacological consequences of receptor oligomerization.\",\n      \"evidence\": \"Bimolecular luminescence complementation and BRET in transfected cells; radioligand cooperativity in primary leukocytes; in vivo air-pouch recruitment model\",\n      \"pmids\": [\"19758998\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Native oligomer composition in tissues not determined\", \"Structural basis of allosteric cooperativity between protomers unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Dynamin-dependent endocytosis was linked to CCR2 signal propagation: dynamin inhibition blocked both CCR2 internalization and ERK1/2 activation, while FROUNT was identified as a CCR2 C-tail interactor that focuses pseudopod formation during chemotaxis.\",\n      \"evidence\": \"Dynasore treatment and clathrin RNAi with phospho-ERK readout; FROUNT co-IP with live-cell pseudopod quantification\",\n      \"pmids\": [\"19643177\", \"19841162\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether FROUNT acts downstream of dynamin-dependent endocytosis not tested\", \"Endosomal signaling compartment identity not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Mutagenesis of chimeric CCR2/CCR5 receptors revealed an intracellular allosteric binding site (NPxxYx₅₆F motif, helix VIII) for small-molecule antagonists, establishing a second druggable pocket distinct from the orthosteric chemokine-binding site.\",\n      \"evidence\": \"Chimeric receptor approach with systematic site-directed mutagenesis and radioligand binding/IP1 functional assays\",\n      \"pmids\": [\"25024169\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal/cryo-EM structure of intracellular allosteric site at time of discovery\", \"Coupling between orthosteric and allosteric sites not biophysically resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identification of CYTL1 as a Gi-coupled CCR2B agonist and filamin A as a regulator of CCR2B endosomal recycling expanded the ligand repertoire and defined post-endocytic trafficking control via FLNa S2152 phosphorylation.\",\n      \"evidence\": \"CYTL1 binding/internalization/chemotaxis with Ccr2−/− validation; FLNa siRNA with super-resolution imaging and FRAP\",\n      \"pmids\": [\"27084102\", \"27909248\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological concentration of CYTL1 at tissue level not established\", \"Kinase responsible for FLNa S2152 phosphorylation downstream of CCR2 not identified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"The cryo-EM structure of CCL2–CCR2–Gαi resolved the molecular basis of ligand recognition and G-protein coupling, showing deep CCL2 N-terminal insertion into the TM bundle and a dominant role for ICL2 over ICL3 in Gα engagement.\",\n      \"evidence\": \"Cryo-EM structure determination with mutagenesis validation of ICL2/ICL3 residues by signaling assay\",\n      \"pmids\": [\"35570218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of CCR2 bound to alternative ligands (CYTL1, defensins, PSMP) not available\", \"Active-state structure without Gα not resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Systematic CRISPR knockout of canonical GPCR trafficking components demonstrated that CCR2 constitutively scavenges CCL2 through a mechanistically novel pathway independent of G proteins, GRKs, β-arrestins, and clathrin, separating scavenging from signaling functions.\",\n      \"evidence\": \"CRISPR KO of G protein, GRK, β-arrestin, and clathrin subunits with quantitative CCL2 scavenging and receptor recycling assays\",\n      \"pmids\": [\"36719944\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular machinery mediating G protein-independent internalization and recycling not identified\", \"Physiological importance of scavenging vs signaling in tissue homeostasis not quantified\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Human autosomal recessive CCR2 deficiency was shown to cause pulmonary alveolar proteinosis and polycystic lung disease, directly linking CCR2 loss-of-function to failed alveolar macrophage homeostasis via impaired monocyte migration.\",\n      \"evidence\": \"Five independent kindreds with homozygous/compound heterozygous loss-of-function variants; Ca²⁺ flux and monocyte migration assays confirming abolished signaling\",\n      \"pmids\": [\"38157855\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CCR2 deficiency also causes susceptibility to infections or other immune phenotypes in humans not yet systematically studied\", \"Genotype–phenotype correlation across different mutation types not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the molecular identity of the scavenging internalization machinery, the structural basis of heterodimer-specific G-protein coupling, and whether the intracellular allosteric site can be therapeutically exploited independently of orthosteric blockade.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Scavenging internalization machinery completely unknown\", \"No structure of CCR2/CCR5 heterodimer\", \"Clinical utility of intracellular allosteric antagonists untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 20, 29, 31]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [30]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [6, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 2, 3, 19, 29]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [14, 19]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [14, 30]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10, 23, 26, 27, 28, 31]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 6, 14, 17, 20, 29]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [25, 28, 31]}\n    ],\n    \"complexes\": [\n      \"CCR2/CCR5 heterodimer\",\n      \"CCR2/CCR5/CXCR4 hetero-oligomer\"\n    ],\n    \"partners\": [\n      \"CCR5\",\n      \"CXCR4\",\n      \"FLNA\",\n      \"TNPO1\",\n      \"FROUNT\",\n      \"CCL2\",\n      \"CYTL1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}